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CHAPTER I 
 
INTRODUCTION 
 
 In order for genetic information to be inherited from one generation to the next, 
the genome of the parent must be faithfully replicated and passed on to the progeny.  
Although DNA replication is one of the most fundamental aspects of life, our 
understanding of how it occurs and how it is regulated in eukaryotic cells is still far from 
complete.  The most basic regulation of DNA replication occurs at the level of the DNA 
itself.  The replicon model originally proposed by Jacob et al. in 1963 (83) (Figure 1) 
hypothesized that specific cis-acting elements (DNA) were acted upon by trans-acting 
elements (proteins) to initiate DNA replication.  This model suggested that DNA 
sequences ultimately determined replication start sites, and that protein factors provided 
the triggering mechanism for the start of new DNA synthesis.  The replicon model has 
since been refined in breadth and detail, but the basic concept has held true.  Although 
many DNA sequences have been identified that are necessary and sufficient to serve as 
origins of DNA replication, it is still unclear how those DNA sequence elements are able 
to dictate if, when, and where DNA replication begins.  
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 Figure 1.  The replicon model 
proposed by Jacob et al. in 1963 (83).  
Reproduced from Aladjem and 
Fanning, 2004 (4). 
 
What Is an Origin of DNA Replication? 
 
 An origin of DNA replication (origin) is a specific sequence that serves as a start 
site for DNA replication, and for the purpose of this dissertation, will also be defined to 
include the nearby DNA sequence elements necessary for DNA replication to start at that 
site.  The replicon model (83) is most applicable in describing the relatively simple 
origin, oriC, found in Escherichia coli.  In this example, the DNA sequence OriC is the 
replicator and the protein DnaA is the initiator (127).  The 265 bp E. coli OriC is 
composed of five binding sites for DnaA, an AT-rich sequence, and binding sites for 
additional auxillary factors (87).  Initiation occurs when helical distortions mediated by 
DnaA oligomerization melt the AT-rich tract, and the open “bubble” of single-stranded 
DNA can serve as a template for replication fork proteins to begin to synthesize new 
DNA (127).     
 Replication origins in budding yeast, the ARS1 model.  In the budding yeast 
Saccharomyces cerevisiae, genome-wide mapping of replication origins by multiple 
techniques has provided a wealth of information about the characteristics of origins (115, 
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152, 179, 214).  Origins in S. cerevisiae tend to be small (100-200 bp), and they are 
composed of multiple necessary sequence elements.  It has been possible to genetically 
and biochemically dissect yeast origins through the use of an Autonomously Replicating 
Sequence (ARS) assay, in which an origin-containing DNA fragment is placed on a 
plasmid with a centromere (32, 180).  The plasmid will replicate autonomously in yeast 
cells in a manner identical to the chromosomes as long as it contains a functional origin 
(Figure 2). 
 
 
Figure 2.  The ARS assay.  Taken from Gilbert, 2004, box1 (60).  DNA fragments can be 
cloned onto a plasmid containing a selectable marker and transformed into yeast cells at 
low copies such that each cell should get no more than 1 plasmid.  The transformed yeast 
are grown in the presence of selection, and surviving colonies contain plasmids with the 
ability to autonomously replicate.  These plasmids are further analyzed for their ability to 
replicate autonomously, and in this manner ARS elements can be identified.   
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Figure 3.  The S. cerevisiae ARS1.  The ~125 bp origin sequence contains four necessary 
sequence elements (yellow boxes) with a single initiation site.  The region is maintained 
free of nucleosomes as shown, with positioned nucleosomes flanking the origin (brown 
half circles).  The ARS consensus sequence (ACS) for all budding yeast origins is shown.     
   
 The best characterized example of a yeast origin is ARS1 (180).  ARS1 is ~125 
bp long and is composed of 4 necessary sequence elements: the ARS consensus sequence 
(ACS), B1, B2, and B3 elements (61, 187) (Figure 3).  The ACS sequence is an 11 bp 
sequence that is conserved with at least a 9/11 bp match in all S. cerevisiae origins.  The 
origin recognition complex (ORC) initiator binds to the ACS and B1 elements and 
recruits additional replication factors.  The B2 element functions as a DNA unwinding 
element and may also serve other roles (111).  The B3 element binds the transcription 
factor Abf1 and maintains a specific chromatin conformation at the origin (120).  New 
DNA synthesis begins at a specific nucleotide between the B1 and B2 elements (19). 
Replication origins in multicellular eukaryotes are larger and more complex.  
Although the basic features of origins in multicellular eukaryotes may be similar to 
budding yeast, they are larger, more complex, and more difficult to study.  For these 
reasons, much less is known about what constitutes an origin of replication in higher 
eukaryotes.  Like origins of S. cerevisiae, origins in multicellular organisms bind ORC 
and have multiple DNA sequences that are necessary for the initiation of DNA 
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replication (4, 60).  However, multicellular eukaryotic origins are ~1-6 kb long and 
contain no recognized consensus sequence.  Chromatin organization has also been 
identified as an important component in origin activity (60).   
 The ARS assay that was so useful in characterizing yeast origins so far has not 
been successfully recapitulated in mammal cells.  The inability to use this tool has slowed 
the progress of research in identifying functional requirements for DNA replication in 
mammals.  Genetic dissection of mammalian origins has relied on the stable integration 
of WT or mutant origins at ectopic chromosomal locations to test the effect of mutations 
on origin function.  Although this strategy works, it is cumbersome, restricting both the 
number of origins analyzed and the range of mutations that can be practically tested.   
 Specific start sites for replication initiation are used to replicate the mammalian 
genome.  However, the determinant for origin specification on mammalian chromosomes 
is still controversial.  In Xenopus oocyte extracts, any sequence can serve as a replication 
start site, arguing that sequence is not a major determinant in origin selection (35).  
Furthermore, ORC seems to bind any DNA sequence equally well (35).  This suggests 
that such factors as transcription, chromatin, and nuclear localization may play dominant 
roles in determining specific start site for DNA replication (35, 60).  However, specific 
sequence elements do contribute to origin selection.  This has been clearly demonstrated 
in multiple investigations that move a DNA fragment containing an origin to an ectopic 
location, where it retains its function as a start site for DNA replication (5, 7, 8, 113, 118, 
141, 203).  Moreover, deletion of short sequences within these ectopic origin fragments 
can cause them to lose origin function (4, 5, 113, 203, 204).  Although specific DNA 
sequences are important for origin function, it is unclear what those sequence elements 
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are doing.  At this time, it is unclear what type of dynamic interaction exists with 
sequence-directed origin selection in the context of other factors such as transcription, 
chromatin, and nuclear organization.              
 
Factors Affecting the Usage of Origins or the Timing of Origin Firing 
 
Nucleosome positioning.  In several model origins in yeast and eukaryotic 
viruses, the ordered positioning of nucleosomes at origins of replication is crucial for 
replication initiation.  In the S. cerevisiae ARS1, the start site for DNA replication is 
maintained free of nucleosomes by the concerted effort of ORC and the transcription 
factor Abf1 (112, 172) (Figure 3).  The Epstein-Barr virus also has a specific pattern of 
positioned nucleosomes at the viral origin, oriP (221).  The concerted action of simian 
virus 40 (SV40) T-antigen and the CHRomatin Accessibility Complex (CHRAC) 
remodels nucleosomes at the SV40 origin, allowing DNA replication to initiate (6, 85).  
Chromatin modifications.  Epigenetic modifications and chromatin remodeling 
have been shown to play a role in the selection and activity of origins, but the exact 
nature of this role is not clear.  The “Jesuit model” (many are called, but few are chosen) 
of site-specific initiation of DNA replication suggests that many more potential origins 
exist in the genome than are normally used (39).  Consistent with this model, Xenopus 
and Drosophila embryos, which lack epigenetic modifications, have tightly spaced (~5 
kb) start sites for DNA replication and no apparent sequence-directed specificity of origin 
selection (81, 103, 161, 201).  Introduction of epigenetic modifications and the definition 
of transcription loci later in development correlate with an increase in inter-origin spacing 
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and a decrease in the total number of origins used (81, 161).  In somatic cells, DNA 
replication start sites are normally restricted to specific locations.   
In Drosophila, origins can be inactivated by targeted histone deacetylation and 
reactivated by targeted histone acetylation (3).  Global disruption of histone deacetylation 
by mutation of the histone deacetylase dmRpd3 leads to an increase in overall DNA 
replication (3).  Consistent with these findings, a similar investigation in S. cerevisiae 
determined that deletion of the histone deacetylase scRpd3 caused individual origins to 
fire earlier in S phase, and targeted tethering of the histone acetyltransferase Gcn5p 
caused a late firing origin to initiate replication early in S phase (198).  Global changes in 
histone acetylation caused by the drug trichostatin A in human cells changes the pattern 
of origin usage at multiple loci (90).              
Transcription, origin usage, and replication timing.  Origins of DNA 
replication are commonly associated with gene promoters and CpG islands (12, 38, 116, 
189).  This association was mostly anecdotal until genome- and chromosome-wide origin 
identification studies were performed in S. cerevisiae and Drosophila, respectively.  
Genome-wide analyses in budding yeast showed that origins were more likely to be 
found near gene promoters, and that transcriptionally active euchromatic regions were 
associated with earlier S phase replication than heterochromatic regions (115, 152, 214).  
A similar chromome-wide investigation in Drosophila focused directly on the 
relationship between origin usage and transcription and found a strong statistical 
correlation between ORC and RNA Pol II localization (116).  Although the link between 
active transcription and early-S phase replication is clearly established, this correlation is 
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not absolute.  Early-firing origins have been identified in heterochromatic regions, and 
vice versa (164).   
There are several possible reasons for the link between transcription and 
replication.  One is that the chromatin environment that favors DNA accessibility for the 
loading of RNA polymerase might also favor the mechanisms for replication initiation.  
Chromatin remodeling complexes associated with gene promoters have been labeled as 
“transcription factors,” but in fact their general purpose is to facilitate the binding of any 
DNA-binding complex (93). An illustration of this concept is seen during V(D)J 
recombination, where transcription factor binding, but not transcription, is required for 
recombination (140, 167).  Another potential reason for the link between replication and 
transcription may involve epigenetic inheritance of modified histones.  Supporting a role 
for DNA replication in epigenetic re-organization, changes in DNA replication at the 
HoxB locus precede, and are necessary for, developmental changes in the transcription of 
the Hox genes (49).        
Multiple investigations link gene activity with replication timing and, in some 
cases, a change in the pattern of origin usage (27, 42, 45, 49, 51, 133, 171).  A survey of 
6 origins of replication associated with CpG islands at gene promoters on the X 
chromosome found that upon X inactivation, CpG methylation, and gene silencing, origin 
usage was not affected, but the timing of replication was delayed (63).  Thus, a certain 
class of origins have a transcriptional link with the timing of their firing in S phase, but 
their overall usage is independent of transcription.  Although it has been a common 
notion to think of replication timing as an effect of transcriptional activity, a recent report 
demonstrated the opposite.  When an origin of replication was integrated with a transgene 
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at a repressive locus, a delay in replication timing precedes histone deacetylation and 
gene silencing (51).  This report supports earlier investigations linking gene activity with 
replication timing (27, 42, 45, 133, 171), but it also adds a new dimension in that the 
delay of replication occurred before gene inactivation and therefore was not a 
consequence of gene inactivation.   
CpG methylation.  The consequence of CpG methylation on replication initiation 
is still unclear.  Rein et al. (1999) reported that at the locus containing the active Chinese 
hamster DHFR origin, most CpG dinucleotides are normally methylated, but in cells that 
have reduced CpG methylation the origin is not active (155).  However, the CpG island 
seen near the c-myc origin of replication is normally not methylated (155), and in 
Xenopus egg extracts DNA methylation prevents ORC assembly and inhibits DNA 
replication (74).  Methylation of a CpG island in the human HPRT gene, and in 6 other 
origins associated with genes and CpG islands on the X chromosome, had no observed 
effect on the usage of an origin located there (34, 63).  These conflicting results suggest 
that the effect of DNA methylation on origin activity may be specific for individual loci, 
and that additional mechanisms may regulate individual origins. 
Drugs inhibiting replication fork progression, and their effect on origin 
selection.  Treatment of cells with aphidicolin will uncouple DNA polymerases from the 
rest of the replication fork, leading to large regions of unwound and unreplicated DNA 
(106, 177).  This uncoupling will quickly lead to a cell-cycle arrest and makes the 
unwound sections of single-stranded DNA susceptible to breakage, leading to a DNA 
damage response (95).  Low doses of aphidicolin slow replication forks without 
completely inhibiting DNA synthesis.  Treatment of cells with the nucleotide synthesis 
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inhibitors hydroxyurea (173), methotrexate, fluorodeoxyuridine, or excess thymidine also 
leads to cell-cycle arrest and activation of a DNA damage response (95, 197).   
Upon depletion of nucleotide pools during S phase, a change in the profile of 
origin usage in hamster cells was observed in which normally dormant origins fired (11, 
37).  The activation of these “dormant” origins is hypothesized to occur in response to the 
slowing of replication forks, so that the slowly replicating portions of the genome will not 
remain unreplicated at the end of S phase.  Supporting this hypothesis, normally dormant 
origins at the yeast HML locus will fire when neighboring early-firing origins are 
inactivated (199).  An explanation for both cases is that at a given locus, multiple origins 
are licensed and ready to initiate replication.  The dominant origin will fires first.  The 
secondary “dormant” origins are passively replicated from forks emanating from the 
dominant origin in a normal setting, but if the dominant origin fails to fire or replication 
forks are slowed, the dormant origins will have time to fire before they are passively 
replicated.  
The Chinese hamster DiHydroFolate Reductase (DHFR) origin beta as a 
model.  The Chinese hamster DHFR origin-beta is one of the best characterized origins 
of DNA replication currently under study.  It will be the focus of some of the 
investigations presented in this thesis.  Ori-beta is the strongest of 3 preferred start sites 
of replication identified in a 55 kb intergenic zone of replication initiation located 
downstream of the dihydrofolate reductase (DHFR) locus in Chinese hamster cells (4, 
189) (Figure 4).  Ori-beta is located 17 kb downstream of the DHFR gene, ori-beta' is 
located approximately 4 kb downstream of ori-beta, and ori-gamma is located 23 bp 
further downstream (9, 23, 24, 44, 76, 92, 105, 144, 205).  Peaks of replication initiation 
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were determined over ori-beta and ori-beta' by quantitation of nascent strands, and the 
valley between these peaks occurred next to a GA+CA dinucleotide repeat (DNR) 
sequence (92), suggesting that DNR may act as a boundary between these two origins. 
Replication initiation at origins in the DHFR intergenic region is linked with 
transcription of the DHFR gene.  Deletion of the DHFR promoter causes a delay in 
replication initiation at origins in the intergenic region that can be reversed by 
substitution with a Drosophila promoter (158).  Transcription termination signals exist at 
the 3’ end of the DHFR gene that block transcription elongation into the intergenic 
region, and deletion of these signals causes a loss of replication initiation in the entire 
intergenic region (126).  Transcription of DHFR and neighboring genes prevents 
replication initiation within the transcribed regions, but this block is suppressed upon 
treatment of the cells with a transcription inhibitor (160).  Thus, many potential origins 
exist at and around the DHFR gene, but transcription limits those chosen to fire. 
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 Figure 4.  The DHFR intergenic region and origin beta.  Necessary sequence features in 
the 5.8 kb BamHI/KpnI ori-beta fragment are shown.  IR, initiation region; RIP60, 60 
kDa replication initiation protein; BEND, sequence-induced bend; AT, 343 bp AT-rich 
region containing (AT)47(A)14(T)20; DNR, 235 bp CA+GA dinucleotide repeat element 
(7, 8).  The 4 bp (gray highlight), bent DNA (underlined), and RIP60 binding site (bold) 
sequences are given.  The DNR element is enlarged to display the composition of its 
nucleotide repeat tracts.     
 
Five cis-acting sequence elements have been identified in the Chinese hamster 
DHFR ori-beta that are necessary for the full activity of the origin when ori-beta is 
integrated at random ectopic locations (7, 8) (Figure 4).  One of the functionally 
important elements in DHFR ori-beta is a 235 bp DNR sequence containing a (CA)19 
(GA)69 dinucleotide repeat.  Deletion of DNR reduced ectopic ori-beta activity ~9-fold 
(7) in hamster cells.  Deletion of the 1.5 kb NK fragment at the 3’ end of ori-beta, which 
contains DNR, reduced ectopic ori-beta activity 3.5-fold (Altman and Fanning, 
unpublished).  These data suggest that the DNR sequence element is required for the 
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origin to function properly.  The second element is identified as a 4 bp sequence, GGCC, 
within a GGGCCC hexanucleotide palindrome.  Deletion of this sequence or replacement 
with CATG reduced ectopic ori-beta activity in hamster cells by at least half (7, 8).  A 
344 bp AT-rich element in ectopic ori-beta was also identified that, when deleted, 
reduced ori-beta activity ~6-fold (7) in both hamster and human cells.  A region of stably 
bent DNA between the ori-beta initiation region and the AT element was shown to be 
important when mutation of the sequences responsible for the bend were mutated and 
ectopic ori-beta initiation activity in hamster cells was lost (8).  Mutation of one of two 
binding sites for the 60 kDa replication initiation protein (RIP60) resulted in a ~5-fold 
decrease in ectopic ori-beta initiation activity in hamster cells (8). Based on these 
analyses of ori-beta, along with similar mutational analyses of the human c-myc (113, 
118), laminB2 (141), and beta-globin origins (5, 203), mammalian origins require 
specific functional elements for replication initiation to occur.      
Interestingly, replacement of the AT element with a similar sequence from the 
human laminB2 origin restored the activity of ectopic ori-beta in hamster or human cells, 
but replacement with a spacer DNA did not (8), thus providing evidence of conservation 
of functional elements between mammalian origins from different species.  This result 
supports the idea that a candidate-based replacement strategy can be used to elucidate the 
function of necessary elements.     
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Replication Dynamics Affecting Tri-Nucleotide Repeat (TNR) Stability 
 
At least 20 genetic diseases are caused by the expansion of trinucleotide repeats, 
including myotonic dystrophy and Huntington’s disease (30, 54, 143).  All TNR diseases 
begin with a “pre-mutation” state when the repeat number becomes unstable for unknown 
reasons. Through successive generations, as the repeats expand, the disease phenotypes 
appear and increase in severity (30, 31, 54, 129, 143).  It is possible that these mutations 
all share a similar mechanism for repeat instability.  However, a “global” change in the 
nucleus or in trans-acting protein factors cannot easily account for the disease-relevant 
repeat expansions, since expansion of repeats occurs at a specific locus, not at multiple 
loci at once (30, 104, 129, 130).  When considering potential mechanisms for repeat 
expansions, it is productive to focus on events or defects that are specific for the disease 
locus, whether that event/defect is a random mistake in normal DNA metabolism, a very 
specific trans-acting protein factor, an epigenetic modification, or a mutation in a cis-
acting DNA sequence.   
Candidate DNA replication origins have been discovered near disease-relevant 
TNRs.  These include the spinal cerebellar ataxia type 7 (SCA-7), Huntington disease 
(HD), and spinal and bulbar muscular atrophy (SBMA) genes (54), as well as the FMR2 
(FRAXE) gene (28).  The FMR2 and FMR1 genes include a similar arrangement of CGG 
repeats, transcriptional start sites, promoters, and CpG islands (54, 55, 66).  Like the 
FMR1 locus, the FMR2 locus is also reported to replicate later in S phase in Fragile X 
patient cells (181), and the origin seems to be localized very close to its CGG repeats.  
For the TNR-proximal HD origin, there was no obvious difference in initiation between 
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affected and unaffected individuals (51).  Although the effect of origin placement on tri-
nucleotide repeat stability has been investigated in model systems, origins near TNR 
tracts have not been extensively characterized, and their implications for TNR stability 
have not been addressed. 
Protein mutations affecting TNRs.  No defective protein factors have been 
implicated in TNR instability in human patients.  However, a genetic approach has been 
taken in S. cerevisiae to understand the contributions of different components of the 
replication machinery, as they relate to TNR expansions and contractions (104, 157).  
The largest effect on TNR stability was observed upon deletion of the Rad27 (Fen1 in 
humans) flap exo/endonuclease protein (50).  Rad27 is involved in the processing of the 
5’ flap of Okazaki fragments during DNA synthesis as well as base excision repair (109).  
Mutations in other proteins involved with Okazaki fragment maturation, namely PCNA 
and DNA ligase, also cause an increase in TNR instability (82, 154, 166).  Specific 
mutations in Rad27, PCNA, and DNA ligase that disrupted their interactions with each 
other had additive effects on TNR instability, suggesting that the defect in loading of 
Rad27 and DNA ligase to Okazaki 5’ flaps by PCNA was the cause of TNR expansion 
(154).  Further supporting a role of lagging strand synthesis in TNR instability, mutations 
in lagging-strand polymerases alpha and delta caused an increase in TNR instability, but 
mutations in the leading-strand polymerase epsilon had no observed effect (165).  
Mutation of the proofreading domain of polymerase delta did not affect TNR stability.  
Rather, the mutations in polymerases alpha and delta should have the effect of slowing 
the rate of Okazaki fragment synthesis (165).  Together, these mutational analyses of 
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replication proteins in S. cerevisiae implicate lagging strand DNA synthesis defects in 
TNR expansions and contraction.                       
Secondary DNA structure formation within TNR sequences.  Disease-relevant 
TNR sequences (CTG, CCG, GAA, and GAC) share the common feature that they are 
capable of forming secondary DNA structures (131).  TNRs that do not readily form 
secondary structures have not been associated with instability and disease.  In each case, 
one strand of the TNR duplex will form a secondary DNA structure more readily than the 
other (CTG>CAG, CGG>>CCG, GTC>GAC), except in the case of GAA repeats in 
which both strands cooperate to form a triplex DNA structure (104, 121, 131).  DNA 
secondary structures such as hairpins can be difficult to process during DNA replication, 
potentially leading to polymerase slippage or stalling (122).     
Replication fork progression and fragile sites.  Common fragile sites in the 
genome include, but are not limited to, microsatellite repeats and other di-, tri-, and poly-
nucleotide repeat tracts.  The fragile site associated with an expanded disease-allele CGG 
repeat tract next to the promoter of the Fragile X Mental Retardation gene (FMR1) is 
normally observed only when progression of replication forks is impeded.  Aphidicolin, 
or nucleotide synthesis inhibitors methotrexate and fluorodeoxyuridine, retard the 
progression of replication forks.  Treatment of Fragile X patient cells with either of these 
drugs results in the appearance of a fragile site at the FMR1 locus, visible on mitotic 
chromosome spreads (Figure 5) (68).   
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Figure 5.  Metaphase X chromosome with the fragile site 
at Xq27.3.  The Giemsa-stain (left) and scanning electron 
micrograph (right) images are adapted from Griffiths et 
al., 1991 (64).  Expression of the fragile site was achieved 
by a deoxycytidine release from a thymidine block.  
Arrows indicate the fragile site in each image.  
 
   
Figure 6.  From Mirkin, 2006, Figure 3 (129).  
In this model, lagging strand synthesis dictates 
whether contraction or expansions occur. (A) If 
the hairpin-forming repeat strand is on the newly 
synthesized Okazaki fragment, expansions in the 
daughter strand are more likely.  (B) If the 
hairpin forming repeat strand is on the lagging 
strand template, contractions in the daughter 
strand are more dominant.  
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Replication models of repeat expansion.  The direction of replication, as well as 
the distance of an origin of replication from the TNR tracts, has been implicated in 
affecting TNR stability (31, 130).  Because repeat instability occurs via lagging strand 
replication machinery, the direction of replication determines whether the hairpin-
forming strand of the repeats will be on the parent or daughter strand (Figure 6).  If the 
hairpin-forming strand is the lagging-strand template, contractions are favored (Figure 
6B); if it is on the daughter strand, expansions are favored (Figure 6A).  Supporting this 
conceptual model, expanded repeats integrated next to origins in E. coli (77, 148, 159), S. 
cerevisiae (13, 50, 128, 145), and COS-1 primate cells (29, 137) display orientation-
specific expansions and contractions.  An in vitro SV40 assay using human cell extracts 
also found that the direction of DNA replication specifies whether expansions or 
contractions occur (142). 
In addition to replication direction, the distance between an origin and TNR tracts 
can affect their stability (29, 137, 142).  This observation has prompted the Okazaki 
Initiation Zone (OIZ) model of repeat stability (31, 130, 143) (Figure 7).  Since 
processing of the 5’ ends of Okazaki fragments is implicated in repeat stability, the 
placement of Okazaki fragment initiation inside or outside repeats is hypothesized to be 
important (30, 31, 129, 130).  If Okazaki fragment synthesis begins within the repeat 
tract, a greater chance for repeat instability is predicted.  Consistent with this hypothesis, 
repeat instability is normally observed as the number of trinucleotide repeats expand 
beyond ~40-50 (120-150 bp), roughly the size of an Okazaki fragment (~135-145 bp) 
(10, 30, 75).  Moreover, as the DNA duplex is unwound with a moving replication fork, 
the leading strand is replicated almost immediately after becoming single-stranded.  In 
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contrast, a portion of the lagging strand is unwound prior to RNA priming and Okazaki 
fragment synthesis.  The OIZ model predicts that if the unwound DNA contains a length 
of trinucleotide repeats sufficient for hairpin formation, this hairpin can form and impede 
DNA synthesis.  Thus, the location of the start of the Okazaki fragment can affect how 
much of the repeats are included, and longer repeats have a greater chance of spanning 
the entire Okazaki fragment. 
The OIZ model also predicts that slowing replication speed would extend the 
amount of time that the repeat tract remains single stranded and increase the chance of 
hairpin formation.  If the OIZ model is correct, slowing replication fork speed should 
increase repeat instability.  This may explain why the fragile site in Fragile X Syndrome 
patient cells is only observed when the cells are grown in replication fork inhibitors such 
as aphidicolin, methotrexate, or fluorodeoxyuridine (36, 52, 62, 135, 182) (Figure 5).  
Also supporting this model, treatment of muscular dystrophy type 1 (DM1) cells with the 
drug emetine, which preferentially inhibits lagging strand synthesis and results in large 
stretches of unwound lagging strand template, resulted in large (up to 170 repeats) 
expansions in the mutant TNR allele (31, 217).          
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Figure 7.  Okazaki Initiation Zone (OIZ) model of repeat instability.  (A) Initiation of 
Okazaki fragments outside the TNR tract (red) results in reduced potential for instability.  
(B) If initiation of Okazaki fragment synthesis shifts such that it occurs within the TNR 
tract (red), there is predicted to be a greater chance for repeat instability due to errors in 
Okazaki fragment 5’ processing and a greater probability of secondary structure 
formation.  Black line, template strand; gray lines, daughter strand; green lines, RNA 
priming site for Okazaki fragment initiation. 
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CHAPTER II 
 
AN ORIGIN OF DNA REPLICATION IN THE PROMOTER REGION OF THE 
HUMAN FRAGILE X MENTAL RETARDATION (FMR1) GENE  
 
Introduction 
 
Fragile X syndrome, the most common form of inherited mental retardation in 
males, is characterized by expansion of a CGG repeat tract in the 5’ untranslated region 
of the human Fragile X Mental Retardation (FMR1) gene on Xq27.3 (139, 186, 191). The 
repeat number expands from 5-50 in normal males to over 200 in affected patients, 
accompanied by methylation of CpG dinucleotides and silencing of FMR1 gene 
expression, giving rise to the disease (139, 186, 191).  DNA methylation of CpG 
dinucleotides in the FMR1 promoter is a necessary step in the inactivation of 
transcription, since FMR1 transcription can be reactivated in Fragile X affected cells 
upon treatment with 5-aza-2-deoxycytidine (73, 146). Moreover, rare individuals, whose 
CGG repeats are expanded but not methylated, still express FMR1 and display normal 
intelligence (67, 147, 174). The cause of the CGG expansion in the patient’s maternal 
lineage is not known, but cis-acting factors are thought to play an important role (30, 104, 
129, 130).    
More than 20 genetic diseases are caused by the expansion of trinucleotide 
repeats, including myotonic dystrophy and Huntington’s disease (30, 54, 143). 
Trinucleotide repeat diseases begin with a “pre-mutation” state when the repeat number 
becomes unstable for unknown reasons. Through successive generations, as the repeats 
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expand, the symptoms of disease appear and increase in severity (30, 31, 54, 129, 143). 
Expansion of trinucleotide repeats can thus be divided into two categories: 1) the initial 
trigger that leads to instability and 2) the mechanism for expansion once the repeat tract 
is lengthened and unstable. The mechanism that first initiates repeat instability may be 
different from the mechanism that propagates repeat lengthening once the repeat tract 
becomes unstable. The expanded repeat length itself may be enough to create instability, 
as observed when expanded CGG tracts are integrated at different loci in Saccharomyces 
cerevisiae and Escherichia coli (13, 77, 104, 168). Instability is thought to occur because 
expanded repeats form extensive stable secondary structures, such as hairpins, triplex, 
and quadruplex DNA, that are difficult to process correctly during replication, 
recombination, or repair (132, 145, 159, 168). In contrast, the initial transition from short, 
stable repeat tracts to longer, unstable ones remains poorly understood. 
 Some evidence has implicated replicon organization as a potential factor in the 
initial expansion of a stable repeat tract. Instability of a wild-type-length CAG repeat 
tract placed within ~350 bp of an SV40 replication origin was observed during viral DNA 
replication in monkey cells (29). In these experiments, the distance between the repeat 
tract and the origin, as well as the orientation of the repeats relative to the origin, affected 
the stability of the repeats. Similar experiments using CGG repeats demonstrated that 
replication fork dynamics, repeat length, and CpG methylation can affect repeat stability 
(137). Orientation-dependent repeat instability was also observed when CGG repeats 
were placed in the E. coli or S. cerevisiae genome near an origin of DNA replication (13, 
159, 208). CGG repeats in the lagging strand template favored contractions, while CGG 
repeats in the newly synthesized Okazaki fragment favored expansions (13, 159, 208). 
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Consistent with the importance of replication direction, trinucleotide repeats can be 
induced to expand or contract in S. cerevisiae by mutating replication proteins involved 
in lagging strand, but not leading strand, DNA synthesis (104, 145, 157, 165, 166). These 
observations point to a potential role for origins of DNA replication in initiating and/or 
exacerbating trinucleotide repeat length instability.     
 In this chapter, I describe experiments to identify origins of DNA replication at 
sites surrounding the CGG repeats in the human FMR1 locus and to monitor their 
initiation activity in cells from normal and Fragile X individuals. An approximately 35 kb 
region surrounding the FMR1 promoter and the repeats was investigated. Initiation 
activity localized in the FMR1 promoter region, and the activity of the FMR1 origin was 
equivalent to that of two previously characterized origins of DNA replication analyzed in 
parallel as controls. The FMR1 origin was active in untransformed fibroblasts derived 
from normal male and female adults and from Fragile X-affected adults. The potential 
role of the FMR1 origin in CGG tract instability is discussed.   
 
Materials and Methods 
 
 Cells and culture conditions.  Cells used for analysis of origin activity at the 
FMR1 locus are described in Table 1. HCT116 and Hela were grown in DMEM with 
10% heat-inactivated fetal bovine serum (FBS) and 5% CO2 at 37° C. All untransformed 
fibroblasts were grown in DMEM with 15% un-inactivated FBS and 5% CO2 at 37° C, 
except GM05381 (grown with 20% FBS) and HAF (grown in 10% heat-inactivated 
FBS).  
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 TABLE 1.  Cells 
Cell Name Description     Sex   Reference  
HCT116 ~diploid colorectal carcinoma  male  (21) 
Hela S3 ~triploid cervical adenocarcinoma  female  (150) 
HAF  primary healthy adenoid fibroblast  male 
GM05381 primary healthy skin fibroblast  male  * 
GM08400 primary healthy fibroblast    female  * 
GM05848 primary FRAXA fibroblast   male  * 
GM04026 primary FRAXA fibroblast   male  (78) * 
GM07072 primary FRAXA fetal lung fibroblast male  (79) *   
*These cells were obtained from the Coriell Cell Repository in Camden, NJ.  More 
information can be found at http://ccr.coriell.org/ 
 
 Southern blot analysis of repeat tract length.  Genomic DNA was isolated from 
cells as described in (8). The isolated genomic DNA was digested overnight with 10 µg 
RNase A at 4° C and purified by phenol/chloroform extraction followed by ethanol 
precipitation. Approximately 50 µg of genomic DNA was digested with PstI (NEB 
#R0140S) and electrophoresed through a 1% agarose gel. The DNA was blotted on a 
Highbond N+ or Highbond XL membrane (Amersham #RPN203B or RPN203S, 
respectively) and crosslinked using a Stratagene UV Stratalinker 1800. The blot was 
prehybridized in 15 mL Church buffer (0.5 M Na2HPO4, 1 mM EDTA, 7% SDS, 1% 
BSA) at 65° C for several hours. Fifty ng of a 1 kb PstI fragment from the FMR1 locus 
which includes the CGG repeats (Figure 8B) was radiolabeled with 50 µCi [alpha-
32P]dCTP (3000ci/mmol, PerkinElmer LAS # BLU513H250UC) using the High Prime 
labeling reagent (Roche # 11585592001). The radiolabeled probe (~50 ng at 1-2 x106 
dpm/ng) was heat denatured in the presence of 750 µg salmon sperm DNA, added to the 
prehybridization solution, and hybridized overnight at 65° C. The blot was washed: twice 
with 2X SSC (300 mM NaCl, 30 mM NaCitrate) and 0.1% SDS for 15 min each at 25° C, 
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once with 1X SSC / 0.1% SDS for 15 min at 25° C, and four times with 0.1X SSC / 0.1% 
SDS for 5 min each at 65° C. The washed blot was exposed to a phosphor imager screen 
to detect the radioactive signal. PstI fragment lengths were verified with at least two 
independent Southern blots for each genomic DNA sample.   
 Reverse-transcriptase PCR. Actively growing cells (~1-3 x 106) were collected 
by trypsinization, and total RNA was extracted using the Qiagen RNeasy Mini kit (cat 
#74104) according to the manufacturer’s instructions. cDNA was synthesized using the 
Invitrogen SuperScript III reverse transcriptase following the manufacturer’s instructions, 
using 1 µg RNA (determined by absorbance at 260 nm) and 500 ng oligo(dT)15 in a 20 
µL reaction at 50° C. Samples (0.5 µL) of the reaction product were then used as a 
template for real-time quantitative PCR. The FMR1 primer set was designed to cross the 
exon 13/14 junction (Appendix Table 3), so that it specifically amplified cDNA from 
spliced mRNA, but not genomic DNA which contained the intervening intron. The 
standard used for this quantitative PCR was serial dilutions of the target PCR amplicon 
from HCT116 cells. Raw values for real-time PCR quantitation of cDNA for all samples 
are provided in the Appendix Table 6.     
Isolation of nascent-strand-enriched DNA. Nascent DNA was isolated from 
asynchronously growing cells as described (113). Briefly, ~7x107 HCT116 cells, ~3x107 
Hela S3 cells, or ~1-3x107 untransformed fibroblasts were harvested by trypsinization 
and loaded onto a 1.25% alkaline agarose gel. After a 15-20 minute alkaline lysis of the 
cells in the well, the DNA was electrophoresed for 16 hours at 30V. Single-stranded 
DNA of 0.5-1 kb or 1-2 kb was cut out of the gel and purified with a Qiagen gel 
extraction kit (cat # 28706) following the manufacturer’s instructions. The DNA was 
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eluted in 10 mM Tris-HCl (pH 8.5) and used directly for quantitative PCR. Between 2 
and 4 independent preparations of nascent DNA were isolated from each cell type.  
 Quantitative PCR primer optimization. PCR primers (PAGE-purified, 
Integrated DNA Technologies) were designed to have similar annealing temperatures and 
to create amplicons approximately 180-200 bp long. Each primer was used to amplify 1.2 
ng of genomic DNA under Quantitative PCR conditions (see “quantitative PCR of 
nascent DNA”) with 2-5 mM Mg++ (final concentration) to empirically optimize the Mg++ 
concentration. The annealing temperature of the primers was also varied to obtain a 
single clean PCR product. Primers were considered optimized when the PCR product 
melted completely at a single temperature (specific for each product), and when the PCR 
product gave a single band of the appropriate size when run on an agarose gel.  A list of 
all primers used is provided in Appendix Table 3. PCR products, melting curve analysis, 
and examples of standard curves are provided in Appendix Figure 21.   
 Quantitative real-time PCR. Fourteen primer sets for the FMR1 locus (Figure 
8), three primer sets for the LaminB2 origin (59) (Figure 11A), and three primer sets for 
the MCM4 origin (96) (Figure 11B) were used to quantitate target sequences in nascent-
strand DNA samples. The LightCycler FastStart DNA master SYBR Green I kit (Roche # 
12239264001) was used following the manufacturer’s instructions. All reactions were 
carried out on a Roche diagnostic real-time PCR LightCycler. Magnesium concentration 
and annealing temperature (Ta) were optimized for each primer (see “quantitative PCR 
primer optimization,” Appendix Table 3 and Appendix Figure 21). For each reaction, the 
cycling parameters were as follows:  10 minutes at 95°; 5 cycles at 95° for 15 sec, Ta+4° 
for 5 sec, and 72° for 15 sec; 5 cycles at 95° for 15 sec, Ta+2° for 5 sec, and 72° for 15 
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sec; 40 cycles at 95° for 15 sec, Ta for 5 sec, and 72° for 15 sec. Some CG-rich amplicons 
used a melting temperature of 96° or 97°. At the end of each run, a melting curve analysis 
was performed in which the PCR products were annealed at 72° and the temperature was 
gradually raised to 99°. In all cases, the PCR products melted in a narrow temperature 
range, indicating a pure PCR product without detectable non-specific amplification 
(Appendix Figure 21).   
To quantitate the abundance of specific target sequences in nascent DNA, 
standard curves of amplification were done using two-fold serial dilutions of XhoI/NarI-
digested HCT116 genomic DNA (50 ng to 0.1 ng). This range of genomic DNA included 
copy numbers of target sequence equivalent to those in the nascent DNA samples. 
Genomic HCT116 DNA digested with NarI only was used as a standard for LaminB2 
amplicons since XhoI cuts within two of the amplicons used. Amplification profiles 
obtained from target sequences in nascent DNA samples were compared to the standard 
curve of cut HCT116 genomic DNA to quantitate the abundance of each target sequence 
in the nascent DNA sample.   
Each PCR reaction was done in duplicate, and the average quantitation from the 
two reactions with every nascent DNA sample with every primer set is provided in the 
Appendix Table 5. For each nascent DNA preparation, relative nascent DNA abundance 
(initiation activity) was calculated by dividing the amount of target sequence in nascent 
DNA at each primer set by the amount of target sequence in nascent DNA at the outlying 
primer set(s) at that locus. Specifically, all values for the control MCM4 primer sets were 
divided by the EX6b value, all values for control LaminB2 primer sets were divided by 
the LB2C1 value, and all values for FMR1 primer sets were divided by the average of the 
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values from primer sets 10, 3, and 20 (see Appendix Table 3 or Figure 11C as an 
example). Initiation activities for like primer sets in different nascent DNA preparations 
of the same cell type were averaged, and standard deviation was calculated based on the 
number (n) of nascent DNA preparations with that cell type.     
Chromatin Immuno-Precipitation (ChIP). 1 x 108 HCT116 cells were washed 
with PBS and treated with 1% formaldehyde in prewarmed medium for 5 min at 37°C. 
Nuclei were prepared based on a protocol by Mendez and Stillman (124) with 
modifications. Briefly, cells were harvested, washed with PBS, and resuspended in 4 mL 
hypotonic buffer A (10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 
10% glycerol, 1 mM DTT, protease inhibitor). Cells were lysed by adding 0.04% Triton 
X-100 and incubated for 10 minutes on ice.  Samples were centrifuged (4 minutes, 1300 
g, 4°C). Nuclei were washed in ice-cold buffer A supplemented with 200 mM NaCl. 
After centrifugation (1300 g, 5 minutes, 4°C),  fixed nuclei were washed with PBS, 
resuspended in 2.7 ml LSB (10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2) and 
lysed by adding 300 µL 20% Sarkosyl. The chromatin was transferred onto a 40 mL 
sucrose cushion (LSB plus 100 mM sucrose) and centrifuged (10 minutes, 4°C, 2500 g). 
Supernatant was removed, and the chromatin was resuspended in 4 mL TE and sonicated 
(Branson sonifier 250-D, 5 output 50 impulse, twice). For partial DNA digests, 3 mM 
CaCl2 and 10 U micrococcal nuclease (Roche) per 1 mg chromatin were added and 
incubated for 10 minutes at 37°C. The reaction was stopped by adding 20 mM EDTA.  
For immunoprecipitation, 1/10 volume of 11x NET (550 mM Tris-HCl pH 7.4, 1.65 M 
NaCl, 5.5 mM EDTA, 5.5% NP40) was added to the extract followed by 10 µg affinity-
purified polyclonal antibodies (HsOrc3p, HsMcm4p), or as control 10 µg rabbit IgG. The 
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immunoprecipitation and purification of co-precipitated DNA was performed as 
described (163).  
Real-time PCR analysis was performed according to the manufacturer’s 
instructions (Roche) using the same parameters and primer pairs described above and in 
Appendix Table 3. “Enrichment” of immunoprecipitated DNA is defined as the 
abundance of target sequence detected in the specific Orc3p or Mcm4p 
immunoprecipitate minus the abundance of target sequence detected by a non-specific 
IgG immunoprecipitate, divided by the abundance of target sequence detected in 30 ng of 
DNA purified from the pre-IP chromatin preparation (162).      
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 Figure 8.  Diagram of the FMR1 gene locus.  (A) A 40 kb region containing part of the 
FMR1 coding sequence and upstream region (Genbank accession # L29074) indicates the 
start site for transcription of the FMR1 gene (bent arrow), with the CGG repeats 
highlighted with a gray triangle.  Above the scale is the FMR1 open reading frame, with 
the first 12 of 17 exons shown as vertical bars.  Below the scale are the locations of the 
outlying primer sets (black boxes) used for quantitative PCR (Appendix Table 3).  (B) A 
detailed diagram of the FMR1 promoter region, with hatches every 100 bp.  Black dots 
indicate the locations of CpG dinucleotides in the sequence.  The FMR1 promoter (box 
with vertical bars), CGG repeat tract (gray box), primary start site for transcription (bent 
arrow), and Exon 1 (white box) are indicated.  PCR amplicons used for quantitative PCR 
(Appendix Table 3) are shown below the scale as horizontal bars, and pertinent restriction 
sites are shown above the scale. 
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 Figure 9.  CGG tract length and FMR1 transcription.  (A) Total genomic DNA from the 
indicated cell cultures was digested with PstI and analyzed by Southern blotting, using 
the radiolabeled 1 kb PstI promoter fragment (Figure 8B) as the probe.  Lanes 1-5 and 9, 
unaffected cells with normal length CGG repeats; lanes 6-8 and 10, Fragile X cells with 
expanded repeat lengths.  (B) One microgram of total RNA from the indicated cells was 
electrophoresed through an agarose gel and stained with ethidium bromide.  (C) Equal 
amounts of total RNA from the indicated cells was reverse-transcribed to cDNA by RT-
PCR, and equal amounts of cDNA were used as template in quantitative, real-time PCR 
with the primer set FMR1 13/14 (Appendix Table 3).  The bars indicate the average 
quantitation from three independent sample preparations for each cell type.  Brackets 
indicate SD.   
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Results 
 
CGG repeat tract length and FMR1 transcription. A panel of human tumor 
cell lines and primary cultures from normal and Fragile X individuals (Table 1) was 
initially characterized by Southern blot to estimate the length of the CGG repeat tract in 
the FMR1 locus. A PstI fragment containing the FMR1 promoter region and the normal 
5-50 CGG repeats has a length of ~1 kb (Figure 8), whereas a full-mutation allele 
containing >200 repeats has a length of over 1.5 kb (147, 211). Blots of PstI-digested 
genomic DNA from Hela S3, HCT116, HAF, and GM05381 cells displayed a PstI 
fragment of approximately 1 kb that hybridized with FMR1 promoter sequences, 
indicating a normal repeat length of ~30 repeats as previously reported for HCT116 cells 
(48) (Figure 9A, lanes 1-5, 9). The Fragile X genomic DNA (GM07072, GM05848, and 
GM04026) displayed PstI fragments of 2-4 kb (Figure 9A, lanes 6-8, 10). The PstI 
fragment lengths for GM05848 and GM04026 were not uniform, suggesting incomplete 
digestion, repeat instability, or mosaicism in the length of the repeat tract in the cell 
population.  Despite the heterogeneity, these results confirm the presence of CGG repeat 
tract expansions in the Fragile X genomic DNA.       
 The expanded CGG tract observed in the Fragile X cells (Figure 9A, lanes 6-8, 
10) predicts that FMR1 expression should be silenced (139, 186). To monitor FMR1 gene 
expression in the Fragile X patient cells, we measured the level of FMR1 transcription by 
quantitative reverse-transcriptase PCR. Equal quantities of RNA from all cells tested 
were used for cDNA synthesis, as determined by absorbance at 260 nm and visualization 
by agarose gel chromatography (Figure 9B, Appendix Table 7). FMR1 mRNA was 
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detected at similar levels in HCT116 cells and in the normal male and female 
untransformed fibroblasts (Figure 9C).  In contrast, FMR1 mRNA levels were suppressed 
by 2-3 orders of magnitude in the Fragile X cells with expanded CGG tracts relative to 
the levels in normal cells (Figure 9C), supporting the prediction that FMR1 transcription 
is silenced (139, 186, 191).         
 
Figure 10.  Flanking (CGG)n repeats reduce PCR amplification efficiency.  Genomic 
HCT116 DNA either undigested (A), digested with XhoI (B), or digested with NarI (C) 
was used as template for real-time PCR amplification with the indicated primer sets in the 
FMR1 promoter region.  Amplification was calibrated using known amounts of 
NarI/XhoI-digested genomic DNA to generate the standard curves.  Arrows indicate the 
locations of XhoI (B) and NarI (C) restriction sites relative to primer locations and the 
CGG repeat tract. 
        
Characteristics of primer amplification in the FMR1 locus. Primers were 
developed to amplify target sequences over a ~35 kb region of the FMR1 locus 
(Appendix Table 3). By varying magnesium concentrations and temperature, primer 
usage was optimized to specifically amplify each target sequence (Appendix Figure 21). 
However, initial characterization of primer efficiency on genomic DNA revealed that 
primers located near the CGG repeat tract displayed lower efficiencies of amplification 
than those located farther from the repeats (Appendix Table 4 and data not shown). These 
preliminary results raised the question of whether the CGG repeats might suppress the 
amplification efficiency of flanking sequences, even though the amplicon did not directly 
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contain the repeats. To test this possibility, we reasoned that if the amplicon template 
were on a separate DNA molecule, its efficiency of amplification should be greater than 
when it was flanked by the repeat tract. To separate the repeats from the amplification 
templates, genomic HCT116 DNA was cut with XhoI (which cuts immediately 
downstream of the repeats), with NarI (which cuts immediately upstream of the repeats), 
or with both NarI and XhoI (see Figure 8B). PCR amplification was carried out with five 
primer sets on each of these genomic DNAs. The NarI/XhoI-digested DNA was used to 
generate the standard curve for these experiments (Figure 10). PCR amplification using 
undigested genomic DNA as template with primer sets 1c and 11 was clearly lower than 
that with the other three primer sets (Figure 10A). When XhoI-digested DNA was used as 
the template, separating the primer set 11 sequence from the CGG tract, amplification 
with primer set 11 increased to a level comparable to that seen with the other three CGG-
distal primer sets (Figure 10B). Conversely, when NarI-digested DNA was the template, 
separating primer set 1c from the CGG tract, amplification with primer set 1c increased 
(Figure 10C). These results demonstrate that the physical linkage of the CGG tract with 
the template DNA reduced the amplification efficiency of the flanking target sequences, 
and that eliminating the linkage with the CGG repeats alleviated the reduction in 
amplification efficiency. Based on these results, HCT116 genomic DNA digested with 
XhoI and NarI was chosen as the calibration standard to quantitate the amplification of 
target sequences in nascent DNA samples.     
Detection of the FMR1 origin of DNA replication in transformed cells. To test 
for initiation activity near the CGG repeats of the FMR1 locus, a fraction enriched in 
short, newly synthesized, single-stranded DNA was prepared from HCT116 cells, which 
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are derived from a male individual and therefore have only one copy of the FMR1 locus 
per cell. As internal controls for each preparation of nascent DNA, real-time quantitative 
PCR was used to measure relative levels of target sequences at the well-characterized 
MCM4 and LaminB2 origins of DNA replication (2, 33, 59, 88, 90, 96, 141, 169, 184, 
190) (Figure 11A, B). The MCM4 and LaminB2 origins showed easily detectable 
initiation activity in HCT116 cells at origin-proximal sequences, well above that at distal 
sequences (Figure 11C).     
Real-time quantitative PCR was used with multiple FMR1 primer sets to measure 
relative levels of target sequences in the same preparations of nascent DNA at sites across 
the FMR1 locus. In HCT116 nascent DNA, a peak of abundance was detected at primer 
set 1.4 adjacent to the FMR1 promoter relative to outlying primer sets, using both the 0.5-
1 kb and the 1-2 kb nascent DNA preparations as templates (Figure 11C). The level of 
initiation activity at the FMR1 promoter was comparable to that at the MCM4 and 
LaminB2 origins in the same preparations of nascent DNA. The pattern of initiation 
activity at the FMR1 locus in HCT116 nascent DNA was identical whether XhoI/NarI-
digested genomic DNA (Figure 11C) or a XhoI/NarI-digested plasmid, containing the 
cloned HCT116 FMR1 sequence, was used as the real-time PCR calibration standard 
(data not shown). 
Measurements of the PCR efficiency of the HCT116 nascent DNA compared to 
that of the XhoI/NarI cut genomic HCT116 DNA standard showed that these two 
templates had nearly identical efficiencies at primer sets EX6b, UPR4, 3, 1.4, and 20, 
validating the peaks of nascent DNA abundance at the MCM4 and FMR1 origins 
(Appendix Table 4). However, the amplification efficiency of primer sets within the 
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FMR1 promoter (1.2, 1c, and 1d) was lower than with the cut genomic DNA used as a 
quantitation standard (Appendix Table 4), resulting in an underestimate of the 1.2, 1c, 
and 1d target sequences in the nascent DNA.  Thus, the peak of FMR1 initiation activity 
detected with primer set 1.4 may actually extend into the promoter, closer to the CGG 
repeats (Figure 8).  
To determine whether replication initiated at the FMR1 origin in other cells, Hela 
S3 nascent DNA was also tested. Since the peak of nascent DNA at primer set 1.4 was 
observed with both HCT116 nascent DNA size classes, only the 0.5-1 kb nascent DNA 
fraction was tested. The initiation activity at MCM4 and LaminB2 origin-proximal 
sequences in two Hela S3 nascent DNA preparations was lower than that in HCT116 
nascent DNA preparations, but still greater than that at distal sequences (Figure 11D). 
Initiation activity was detected with several closely spaced primer sets in the FMR1 
promoter region (Figure 11D). Even though the level of initiation activity in the FMR1 
origin was lower in Hela S3 than in HCT116 cells, it was similar to the initiation 
activities seen at the MCM4 and LaminB2 control origins in the same preparations of 
nascent DNA. Relative to the control origins, the FMR1 initiation activity was equivalent 
in that in HCT116 and Hela S3 cells.  
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Figure 11.  Replication initiates at the FMR1 locus in human cell lines.  (A, B) As 
internal standards in each preparation of nascent DNA, initiation activity was measured at 
the human MCM4 and LaminB2 loci.  Gene exons (thick lines), introns (thin lines), 
transcriptional start sites (bent arrows), and primer set locations (black boxes; Appendix 
Table 3) are shown below the scales.  The location of the Origin of Bidirectional 
Replication (OBR) has been mapped approximately in the MCM4 locus (96) (A) and at 
high resolution in the LaminB2 locus (2) (B). Locations in bp are shown on the scale 
relative to Genbank accession # U63630 for the MCM4 locus (A) and to the OBR for the 
LaminB2 locus (B). (C) DNA sequence abundance at the indicated regions of the FMR1 
locus in 4 independent HCT116 nascent DNA samples (n=4).  “Initiation activity” 
calculations are described in Materials and Methods.  Black bars indicate 0.5-1 kb 
nascent DNA, and white bars indicate 1-2 kb nascent DNA. *, not tested.  (D) Abundance 
of indicated FMR1 sequences in 0.5-1 kb nascent DNA from 2 independent Hela S3 cell 
samples (n=2).  Brackets in panels C and D indicate the SD for the indicated number of 
nascent DNA preparations (n). 
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Figure 12.  Orc3p and Mcm4p localize to the FMR1 promoter in vivo.  A ChIP assay was 
done on 3 independently prepared samples from asynchronously growing HCT116 cells 
for Orc3p (A, B) and Mcm4p (B, C).  (A) “Enrichment” for Orc3p and Mcm4p, as 
described in Materials and Methods, was tested using primer sets at the MCM4 origin 
(Figure 11B, Appendix Table 3), Enrichment was measured at the MCM4 origin (primer 
set UPR4) for Orc3p and Mcm4p relative to the outlying primer set EX6b.  Enrichment 
for Orc3p (B) and Mcm4p (C) was tested using primer sets at the FMR1 locus (Figure 8, 
Appendix Table 3), with peaks of enrichment detected at primer set 1d in the FMR1 
promoter.  Brackets indicate SD of multiple independent immunoprecipitates.   
 
Orc and Mcm proteins associate with the FMR1 origin in vivo. During the G1 
phase of the cell cycle, licensed replication origins are bound by pre-replication proteins 
such as Orc1-6p and Mcm2-7p (1, 89, 96, 162, 190). If an origin of DNA replication 
exists in or near the promoter of the FMR1 gene, as suggested by nascent DNA 
abundance assays (Figure 11), pre-replication complexes would be expected to assemble 
in this region. To test this prediction, we used a Chromatin Immuno-Precipitation (ChIP) 
assay. As a control, we first confirmed enrichment of Orc3p and Mcm4p at the MCM4 
origin (UPR4 primer pair) relative to a distal control region (Ex6 primer pair) (Figure 
12A). In the FMR1 locus, the greatest enrichment of Orc3p was detected with primer set 
1d at the FMR1 promoter region and slightly lower enrichment with primer set 1.5 
(Figure 12B). Orc3p bound to origin-distal chromatin was detected with the outlying 
primer sites 3, 10, 16, and 30, but at significantly lower levels. With primer pairs 5 and 
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11, no Orc3p binding to chromatin was observed. Consistent with these findings, the 
greatest binding of Mcm4p in the FMR1 locus was detected at primer set 1d, with lower 
enrichment at the other primer sets (Figure 12C). The specific binding of Orc3p and 
Mcm4p within the FMR1 promoter is consistent with the existence of an origin of DNA 
replication in this region.               
FMR1 origin activity in untransformed fibroblasts. The activity of the FMR1 
origin was measured in nascent DNA isolated from untransformed human fibroblasts to 
test whether the initiation site detected in the HCT116 tumor cell line is also utilized in 
normal human cells. The peak initiation activity detected at the FMR1 origin in either 
HAF or GM05381 nascent DNA was equivalent to that at the MCM4 and LaminB2 
control origins (Figure 13A and 13B), suggesting that the FMR1 origin is fully active in 
these normal male cells. The FMR1 origin in normal female cells (GM08400) showed 
initiation activity at closely spaced primer sets 1.5, 1.4, and 1c in the promoter region 
(Figure 13C). The level of FMR1 initiation activity in the female cells was nearly as high 
as that of the MCM4 control origin.  
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 Figure 13. Replication initiates at the FMR1 origin in normal male and female 
fibroblasts. As described in Figure 11 and in Materials and Methods, initiation activity 
was tested with primer sets at the FMR1 locus in independent nascent DNA preparations 
from HAF male cells (panel A, n=2), GM05381 male cells (panel B, n=4), and GM08400 
female cells (panel C, n=2). Initiation activity was tested in the same nascent DNA 
preparations using primer sets from the MCM4 and LaminB2 control origins.  Brackets 
indicate the SD for the indicated number of nascent DNA preparations (n). 
 40
 Figure 14. Replication initiates at the FMR1 origin in Fragile X cells. As described in 
Figure 11 and under Materials and Methods, initiation activity was tested with primer sets 
at the FMR1 locus in independent nascent DNA preparations from GM05848 male 
patient cells (panel A, n=2), GM04026 male patient cells (panel B, n=2), and GM07072 
male fetal patient cells (panel C, n=3). Initiation activity was tested in the same nascent 
DNA preparations using primer sets from the MCM4 and LaminB2 control origins. 
Brackets indicate the SD for the indicated number of nascent DNA preparations (n).    
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FMR1 origin activity in Fragile X affected cells. FMR1 origin activity was 
tested in cells from three individuals affected with Fragile X syndrome to determine 
whether the site or the level of activity differed from that observed in normal cells. 
Importantly, the same site of initiation of DNA replication in the FMR1 locus was used in 
cells from all three affected individuals (Figure 14). The levels of initiation activity at the 
FMR1 origin in the two adult patient cells, GM05848 and GM04026, were similar 
(Figure 14A, 14B) to that observed in normal male fibroblasts. However, initiation 
activity at the MCM4 and LaminB2 origins was lower in the Fragile X cells than in the 
normal male cells. These comparisons suggest that the FMR1 origin is at least as active in 
the adult Fragile X cells as in the normal male cells, and perhaps more active. 
Unexpectedly, in three independent preparations of nascent strand-enriched DNA 
from fibroblasts from a 22-week old fetus with Fragile X, GM07072, initiation activity at 
the FMR1 origin was reproducibly lower than in any of the other cells tested (Figure 
14C). In contrast, GM07072 cells displayed strong initiation activity at the MCM4 and 
LaminB2 origins, comparable to that observed in normal cells (compare Figure 14C to 
Figure 13). These controls argue against the possibility that the low activity of the FMR1 
origin in these nascent DNA fractions was due to poor nascent strand enrichment or slow 
cell growth. We conclude that the FMR1 origin activity in the Fragile X fibroblasts from 
this individual was low.    
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Discussion 
 
 Detection of a novel origin of DNA replication at the FMR1 promoter. We 
have mapped a peak of replication initiation in the promoter region of the human FMR1 
gene that displays initiation activity comparable to that of known origins tested in the 
same nascent DNA preparations (Figure 11, 13). The co-localization of Orc and Mcm 
proteins (Figure 12) with the peak of initiation activity further supports the identification 
of the FMR1 origin of DNA replication. The lack of nascent DNA enrichment at primer 
sets distal from the FMR1 origin suggests that this is the primary initiation site within a 
35 kb region flanking the FMR1 promoter and CGG repeats (Figure 11C and data not 
shown). These features of the FMR1 origin identify it as a new member of a class of 
origins that reside near CpG islands and the promoters of housekeeping genes (12, 34, 38, 
63, 116, 189).  
The low efficiency of PCR amplification at target sequences flanking the CGG 
repeat tract limited the region of accurate PCR quantitation of target sequences in 
genomic DNA, but was alleviated by cleaving the template away from the repeats (Figure 
10). Since the same limitation applies to quantitation of CGG-proximal target sequences 
in the single-stranded nascent DNA fraction (Appendix Table 4), the abundance of target 
sequences detected by primer sets 1.2, 1c, and 1d is somewhat underestimated. Hence, 
the peak of initiation activity may include these target sequences in the promoter (Figures 
11C, D, 13, 14). Our results illustrate the effects that unequal PCR efficiencies can have 
on the accuracy of quantitation, warranting caution in interpreting peaks of nascent DNA 
abundance near sequences such as trinucleotide repeats.    
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Differential regulation of the FMR1 promoter and FMR1 origin in Fragile X 
patient cells. The FMR1 promoter region has a complex architecture of bent DNA, CG-
rich tracts, a (CAAAC)6 tract, occupancy by multiple transcription factors (53, 73, 94, 
110, 175, 176) and replication factors (Figure 12). The contributions of these features to 
FMR1 origin activity remain to be determined. Methylation of CpG dinucleotides (53, 
139, 191), remodeling of chromatin (53, 73), and loss of transcription factor binding 
(175, 176) have been reported in the promoter of Fragile X somatic cells. The FMR1 
origin is as active in adult Fragile X patient cells as in normal male cells (Figure 13 and 
14). Since transcription of FMR1 is silenced in the patient cells (Figure 9B), the FMR1 
origin activity is maintained regardless of transcriptional activity.  
The transcriptionally silent FMR1 locus in Fragile X patients replicates later in S 
phase than does the active FMR1 locus in unaffected individuals (70-72, 181, 218). Since 
our data show that the FMR1 origin was active in GM04026 cells (Figure 14B), and these 
cells were previously shown to have delayed replication in the Fragile X locus (71), 
transcriptional silencing is correlated with a delay of replication timing but not FMR1 
origin usage.    
The position and usage of the FMR1 origin has implications for CGG repeat 
stability. A replication fork emanating from the FMR1 origin would replicate the CGG 
repeats such that the CGG sequence is the lagging strand template and the CCG 
complement would be in the newly synthesized Okazaki fragment (Figure 15). The CGG 
repeats more readily form stable DNA secondary structures such as hairpins than their 
CCG complement (104, 129-132, 219). Hairpin-forming trinucleotide repeats appear to 
be more prone to instability when located in the lagging strand template, favoring 
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contractions over expansions (30, 104, 129, 145, 156, 157, 159, 193, 208). Thus, the 
position of the FMR1 origin relative to the CGG repeat tract suggests that it might 
normally favor contractions when replicating unstable repeats.   
 
 
Figure 15.  Model of replication fork movement originating from the FMR1 origin.  
Black lines represent the template strand, and gray arrows indicate the daughter leading 
and lagging strands.  A dashed line indicates the transition point between leading and 
lagging strand synthesis.  The lagging strand template thus contains the CGG repeats 
within 600 bp downstream from the initiation site.  CGG more readily forms secondary 
structures than CCG, and DNA secondary structure formation in the lagging strand 
template is implicated in repeat instability, favoring contractions (104, 129, 130). 
 
 If the direction of DNA replication plays a role in expansion of the CGG repeats, 
one can hypothesize that a change in the pattern of origin usage, such that the CGG 
repeats are not replicated from the normal somatic FMR1 origin mapped here, could lead 
to repeat instability (130). The expansions seen in Fragile X patients occur through 
maternal transmission, and the repeat instability associated with transmission of the 
Fragile X allele is mostly specific to gametogenesis and/or early embryogenesis (30, 119, 
134). During early development, the pattern of origin usage in humans is not known, but 
in model systems such as Xenopus and Drosophila, origin usage is relatively non-specific 
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during early development (81, 103, 161, 201). A different pattern of origin usage during 
early human development might provide a time window in which the repeats would 
escape the stable or potentially contraction-favoring pattern of replication offered by the 
somatic FMR1 origin reported here, and therefore become more susceptible to repeat 
expansion. One of three patient samples used in this study, GM07072, was derived from 
a 22-week fetus and showed reduced usage of the FMR1 origin, in relation to the MCM4 
and LaminB2 control origins (Figure 14C). Although only one prenatal Fragile X 
individual has been examined, these results hint at a potential developmental change in 
origin usage.  Analysis of normal and Fragile X cells from several individuals at different 
prenatal developmental stages will be needed to explore this possibility.   
Other mechanisms known to cause transient changes in the pattern of origin usage 
are depletion of nucleotide pools during DNA replication (11, 37), global changes in 
histone acetylation (90), and agents that induce replication stress (47, 199). If a dormant 
origin on the downstream side of the CGG repeat tract became transiently activated in 
response to DNA replication stress, its position would tend to favor repeat expansion.  
Since the position of the FMR1 origin would be predicted to favor CGG tract 
contractions in FMR1 patients (31, 104, 129, 130, 145, 157), why are they not more 
commonly observed in somatic cells of patients? An emerging role for CpG methylation 
in the stabilization of CGG repeats may give clues to this question.  Methylation 
stabilizes CGG repeats in E. coli (138) and in primate cells in culture (137). The timing 
of CGG repeat instability, prior to germline segregation in early human development, 
coincides with the period in which the DNA lacks epigenetic modifications such as CpG 
methylation (30, 119).  After this time, the repeats are stable and methylated, except in 
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the case of the male testes and sperm, which are unmethylated and display contractions 
(119, 185).  An exception occurs in some high-functioning Fragile X patients who 
display mosaicism for repeat length and methylation (67, 174). Hypermethylated Fragile 
X cells display homogeneous and stable repeat lengths, but unmethylated repeats are 
heterogeneous for repeat length and stability (30, 56, 211, 212). Since the position of the 
FMR1 origin is predicted to favor contraction events, the hypomethylation and 
consequent instability of the expanded repeats in spermatocytes may provide a 
mechanism by which the repeats contract in these cells. This phenomenon could occur 
through normal DNA replication from the FMR1 origin. Postnatal somatic cells in the 
same individual would have hypermethylated, stable repeats that would resist contraction 
during normal DNA replication.  
In summary, the results presented here indicate that an origin of DNA replication 
exists in the promoter region of the FMR1 gene, and that this origin is active in somatic 
cells with either normal-length or expanded CGG repeats, regardless of FMR1 
transcription. The discovery and characterization of the FMR1 origin opens the 
possibility of exploring the relationship of a trinucleotide repeat sequence with its native 
origin of DNA replication.       
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CHAPTER III 
 
DISCRETE FUNCTIONAL ELEMENTS REQUIRED FOR INITIATION ACTIVITY 
OF THE CHINESE HAMSTER DIHYDROFOLATE REDUCTASE ORIGIN BETA AT 
ECTOPIC CHROMOSOMAL SITES 
 
 
Introduction   
 
More than 40 years ago Jacob et al. (83) proposed a DNA replicon model which 
led to the discovery of replicators from bacteria to mammals (60, 61). A replicator is a 
cis-acting genetic element that directs replication initiation to occur at a specific location 
recognized by a trans-acting initiator. Budding yeast Saccharomyces cerevisiae use DNA 
replicators that contain a short consensus sequence that interacts with the origin 
recognition complex (ORC) (15).  Genetic, biochemical, and physical mapping of origins 
of DNA replication on mammalian chromosomes suggests the existence of replicators 
that may specify DNA replication initiation sites in mammalian cells (5, 7, 8, 92, 113, 
118).  Moreover, ORC and its role in the initiation of DNA replication are conserved 
from yeast to mammals, indicating that mammalian replicators might share some features 
with those of budding yeast (1, 14, 35, 89, 96, 107, 117, 125, 190). However, unlike 
replicators in budding yeast, the cis-acting sequence elements that contribute to initiation 
activity of mammalian replicators have no consensus sequence except for a small AT-rich 
sequence bias (60, 61, 203).  
To identify a chromosomal replicator in mammalian cells, an origin DNA 
fragment is placed at an ectopic chromosomal site and assayed for its capacity to direct 
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initiation of replication at the ectopic site.  To achieve this, two general strategies have 
been used.  Using a non-specific integration system, the 5.8 kb Chinese hamster DHFR 
origin beta (ori-beta) (7, 8) and the 1.2 kb human LaminB2 origin (141) showed 
replication initiation activity at multiple chromosomal sites in mammalian cells.  These 
functioned as active replicators in pooled stably transfected cells or individual cell clones, 
although DNA replication activity varied at different chromosomal sites.  The second 
strategy employed FLP- or Cre-mediated specific recombination integration systems to 
introduce the 2.4 kb human c-myc origin (113, 118) and the 2.6 and 3.2 kb human beta-
globin origins (5, 203, 204) into unique ectopic chromosomal sites in a human cell line 
and a mouse cell line, respectively.  The c-myc and beta globin origins serve as 
replicators at their specific ectopic chromosomal sites. Whether the two different 
strategies are equally effective in identifying mammalian replicators has so far not been 
validated by directly comparing them with the same mammalian origin. 
One of the obstacles to understanding mammalian origins is the lack of 
identifiable sequence homology between different origins, but even in budding yeast 
replicators, some elements are not conserved, e.g. the B2 element in ARS1 (210) and the 
binding site for the Abf1 transcription factor in the ARS1 replicator (43, 120, 152, 179, 
214). Interestingly, an Sp1 binding site can functionally replace the Abf1 site in ARS1 
(215), suggesting that yeast replicators lacking an Abf1 site contain other elements that 
may serve the same functional role in directing initiation of replication. Moreover, these 
results suggest a hypothesis that may explain the DNA sequence diversity among 
mammalian replicators and that can be experimentally addressed. 
 49
The mammalian replicators characterized so far are composed of multiple 
sequence elements, of which several are required for initiation activity of the replicator. 
Five sequence elements identified within the 5.8 kb DHFR ori-beta fragment are 
necessary for full initiation activity of ori-beta at ectopic locations in Chinese hamster 
cells (7, 8).  These include a 4 bp GGCC within a GGGCCC palindrome within the peak 
of initiation activity, an AT-rich element (AT), a CA+GA dinucleotide repeat element 
(DNR), a region of bent DNA, and a binding site for the 60 kDa Replication Initiation 
Protein (RIP60) (Figure 16).  A sixth element (not shown) was dispensable for activity 
(7). Importantly, the hamster ori-beta AT element could be functionally replaced by a 
non-homologous sequence from the human laminB2 origin (8), consistent with the 
hypothesis that dissimilar DNA sequences from different mammalian replicators may 
serve similar functional roles. Further support for the concept that replicator elements that 
differ in DNA sequence can functionally substitute for each other comes from the ability 
of a Gal4-binding site to replace a 1.4 kb element in the 2.4 kb ectopic c-myc replicator 
in Hela cells expressing Gal4-CREB, but not Gal4 alone (58).  
In this chapter, I will describe DNA sequences in the DNR element of hamster 
ori-beta that are crucial for full initiation activity of the ori-beta replicator at random 
ectopic chromosomal sites in hamster cells. We present evidence that either the Xenopus 
5S ribosomal RNA gene or an element from the murine 28S ribosomal RNA regulatory 
region can replace the function of the DNR element to restore ori-beta initiation activity.  
Lastly, we demonstrate the requirement for DNR and the other ori-beta elements for 
replicator activity at ectopic chromosomal sites in human cells, using both the specific 
and non-specific integration strategies.   
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Figure 16. The DHFR origin beta at endogenous and ectopic locations. (A) Diagram of 
the endogenous DHFR ori-beta IR in hamster cell. Preferred start sites of DNA 
replication (ori-β, ori-β’, and ori γ) within a 55-kb initiation zone between the genes 
DHFR and 2BE2121 are indicated. The 5.8 kb DNA fragment containing ori-beta extends 
from the BamHI (nucleotide position 1) to the KpnI restriction enzyme site. Previously 
identified (7, 8) functional elements of ori-beta are indicated: IR, initiation region; RIP60, 
60 kDa replication initiation protein binding sites; BEND, sequence-induced stable bend 
in the DNA;  AT, (AT)n repeats and AT-rich sequences; DNR, GA+CA dinucleotide 
repeat element. (B) 5.8 kb ori-beta sequence cloned into pUC19 (pMCD) and integrated 
at non-specific ectopic locations in DR12 and Hela cells. Locations of pp8, pp2, pp6 and 
pp3 PCR primer sites are indicated by gray diamonds. (C) 5.8 kb ori-beta sequence 
integrated at the FRT site in Hela 406 cells (113). The locations of the FRT sites, 
hygromycin-neomycin resistance fusion gene (HygR NeoR) with transcription start site 
(bent arrow), poly-adenylation and transcription termination site (pA), and thymidine 
kinase (TK) gene are indicated.  The 5.6 kb EcoRI fragment used for Southern blot 
analysis, and diagnostic PCR primers 1, 2, and 3 for specific site integration are shown.  
The target sites for ppHyg and pp2b are indicated with gray diamonds.   
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Materials and Methods 
 
Plasmid construction.  The plasmid pMCD containing DHFR ori-beta, a 5.8-kb 
BamHI-KpnI fragment in pUC19, was the kind gift of N. Heinz (25).  Mutant constructs 
pMCD∆DNR, pMCD∆AT, pRIP DSx, and pBENDx were described previously (7, 8).  
Full-length DHFR ori-beta and its mutant derivatives were subcloned into the plasmid 
pFRT.Myc (113) to replace the BamHI-NotI fragment including the 2.4 kb c-myc 
replicator, and named pFRT.ori-beta, pFRT.DNR, pFRT.AT, pFRT.RIP, and 
pFRT.BENT, individually.  The DNR reversed mutant (pMCD-DNRrev) was generated 
by digesting pMCD with NheI and partially with XbaI to release the DNR fragment, then 
ligating its compatible cohesive ends back into the vacant DNR location in pMCD and 
screening for integrations in the opposite orientation.  The resulting DNRrev mutation 
was subcloned from pMCD into the pFRT vector to make pFRT.DNRrev. The XK 
deletion mutant was made by digesting pMCD fully with KpnI and partially with XbaI, to 
delete a 1.3 kb fragment from nucleotide 4454-5781 (relative to the BamHI site) to make 
the plasmid pMCD∆XK.  
Construction of the following DNR mutants used the same strategy: pMCD-
0.5DNR1, pMCD-0.5DNR2, pMCD-DNRspcr, pMCD-SB2r, pMCD-5SRNA, pMCD-
5SNPEf, and pMCD-5SNPEr.  The SB2 insert (57, 114) came from the plasmid pUC-
SB2+ and was the kind gift of F. Grummt.  The 5S RNA insert (188) came from the 
plasmid pXP10 and was the kind gift of J.J. Hayes.  Each mutant construct used a 
derivative of pMCD (pMCD-X) in which the TCTAGA XbaI site at the downstream 
border of DNR was changed to a CCCGGG XmaI site for easier cloning.  For each 
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construct, the DNR element was removed by NheI/XmaI digestion, and the vacant gap 
was filled by ligation of a PCR-amplified fragment flanked with NheI- and XmaI-
compatible cohesive ends.  PCR primers used to amplify the replacement fragments are 
provided in Appendix Table 3.  All changes to the normal ori-beta sequence were verified 
by sequencing.  The DNRspcr mutation was subcloned from pMCD into the pFRT vector 
to make pFRT.DNRspcr.    
Cell culture and stable transfection.  Hela S3 (ATCC CCL-2.2) and DR12 (86) 
cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% FCS at 
37°C with 10% CO2.  Hela 406 cells, a kind gift from M. Leffak, were previously derived 
from Hela cells by integration of an FLP recombinase target site (FRT) (118) and 
maintained in Dulbecco's modified Eagle medium with 10% FBS and 50 µg of 
gentamicin/ml at 37°C with 5% CO2. 
Four µg of pMCD plasmid DNA or a mutant derivative plasmid mixed in a 3:1 
molar ratio with PvuI-linearized pSV2neo DNA, were electroporated into either 5 x 106 
Hela or DR12 cells using a Bio-Rad Gene Pulser at 360 V and 650 µF. After 3-4 weeks 
of growth under G418 (0.5 mg/ml) selection, ~100-200 G418 resistant clones per 
transfection were pooled for further analysis.  
Hela 406 cell transfections were performed using Lipofectamine 2000 (Gibco-
BRL) according to the manufacturer’s instructions. For each transfection in a 24-well 
plate the total amount of DNA was 1 µg; the molar ratio of the donor plasmid to the 
cotransfected, FLP recombinase-expressing plasmid, pOG44, was 1:8. At 24- to 48-hrs 
post-transfection, selection for G418 resistance (0.5 ng of active component per ml of 
culture medium) was initiated and continued for 15 days. After single colonies formed, 20 
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µM ganciclovir was supplied for 2 to 3 days. Colonies resistant to hygromycin, G418, 
and ganciclovir were used for further analysis.  
Diagnostic PCR screening for site-specific integration in the Hela genome. 
After using the site-specific FRT-mediated integration strategy, single-clone colonies 
resistant to hygromycin, G418, and ganciclovir were screened for site-specific integration 
by diagnostic PCR as previously described (113).  Briefly, genomic DNA isolated from 
resistant colonies was amplified by PCR with the diagnostic primer sets 1+2 or 1+3 
(Figure 16C).  A PCR amplicon that spans the FRT acceptor site using the 1+2 primer set 
will be detected when no DNA is integrated.  Upon integration of DNA at the FRT site 
the amplicon size becomes too long to amplify under the PCR conditions used.  A PCR 
amplification product from primers 1+3 can be detected only when the NeoR gene has 
integrated next to the HygR gene at the FRT site.     
Southern blots.  For the non-specific integration system, 10 or 40 µg genomic 
DNA from uncloned pools of pMCD-transfected cells was digested with BamHI/KpnI 
and electrophoresed through a 1% agarose gel.  The DNA was blotted on a Highbond N+ 
(Amersham #RPN203B) and crosslinked using a Stratagene UV Stratalinker 1800.  The 
blot was prehybridized in 15 mL Church buffer (0.5 M Na2HPO4, 1 mM EDTA, 7% 
SDS, 1% BSA) at 65° C for several hours.  The ectopically integrated ori-beta fragment 
was detected using two ori-beta probes, probe 1 and probe 2.  Probe 1 is a 486 bp 
BamHI/StuI fragment at the 5’ end of 5.8 kb ori-beta, and Probe 2 is a 484 bp NsiI/KpnI 
fragment at the 3’ end of 5.8 kb ori-beta.  The GNAI3 probe is a 505 bp PCR fragment 
from the GNAI3 locus in Chinese hamster cells (nt 4623 to 5128, Genbank Accession # 
X79282) amplified by the following primers: 5’ ATGCTAATTGTAGTAGTGATCC and 
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5’ CCTCAAAAGGCACTGCTCC.  The GNAI3 probe hybridizes to a 3.5 kb 
BamHI/KpnI fragment.  Fifty ng of each probe fragment was radiolabeled with 50 µCi 
[alpha-32P]dCTP (3000ci/mmol, PerkinElmer LAS # BLU513H250UC) using the High 
Prime labeling reagent (Roche # 11585592001).  The radiolabeled probe (~50 ng at 1-2 
x106 dpm/ng) was heat denatured in the presence of 750 µg salmon sperm DNA, added to 
the prehybridization solution, and hybridized overnight at 65° C.  The blot was washed: 
twice with 2X SSC (300 mM NaCl, 30 mM NaCitrate) and 0.1% SDS for 15 min each at 
25° C, once with 1X SSC / 0.1% SDS for 15 min at 25° C, and four times with 0.1X SSC 
/ 0.1% SDS for 5 min each at 65° C.  The washed blot was exposed to a phosphor imager 
screen to detect the radioactive signal.   
For the specific integration system, Southern blot analysis was performed using 
standard methods with 10 µg of genomic DNA and hybridizing with either the 756 bp 
EcoRI/XbaI fragment of the Hyg gene from plasmid pFRT.Hyg.TK or the 405 bp 
NcoI/SmaI fragment of the Neo gene from pFRT.myc, as previously described (113).   
Nascent DNA isolation and PCR-based nascent DNA strand abundance 
assay.   For the non-specific integration system in DR12 or Hela cells, ~0.4-2 kb nascent 
DNA isolation using neutral sucrose gradient size fractionation was carried out as 
previous described (7, 8).  Target sequence quantitation in nascent DNA-enriched 
fractions was done using competitive PCR for Hela samples as described (7, 8) or by 
Real-time PCR for DR12 samples.  To test the initiation activity of origin constructs at 
the specific integration site at Hela chromosome 18, 1-2 kb nascent DNA was isolated by 
alkaline agarose gel size chromatography as previously described (113), and target 
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sequence quantitation of a nascent-enriched DNA fraction was done using Real-time 
PCR. Primer sequences are provided in Appendix Table 3.      
The LightCycler FastStart DNA master SYBR Green I kit (Roche # 
12239264001) was used for Real-time PCR quantitation following the 
manufacturer’s instructions.  All reactions were carried out on a Roche diagnostic 
real-time PCR LightCycler.  The total volume of each PCR reaction was 10 µl with 
3.5 mM Mg++, 500 nM of each primer (Integrated DNA Technologies, Inc), and 3 
µl of sample DNA.  Reactions were started with 10 min at 95 o C, 3 cycles using the 
highest annealing temperature, and 3 cycles using the intermediate annealing 
temperature, followed by 39 cycles using the lowest annealing temperature. 
Fluorescence measurements were taken only during the last 39 cycles. During the 
final 3-sec step of each cycle when fluorescence was measured, the temperature was 
elevated to minimize any signals emitted by primer dimers and non-specific PCR 
products with melting temperatures below that of the target.  Calibration curves 
were generated using serial dilutions of a known concentration of pre-sheared 
genomic DNA from the 406/pFRT.ori-beta cell line when using the specific 
integration system, or ScaI-linearized pMCD when using the non-specific 
integration system. 
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Table 2.  PCR primer sequences for the amplification of DNR replacement fragments 
 
Replacement  nt.a  Sequence (5’ to 3’)b    Template    Insert (bp)     
DNRspcr 1202  AGTCTAGACAGCTTTTTCCTTTGTGGTGT pSV2-neoc  235 
  1429 CATCCCGGGACTGGTGGAATGCCTTTAATG  
0.5DNR1 3558 AAGGACCTCAGCCTCTGAAAC  pMCDd       132 
  4351 ATGCCCCGGGTCTCTGCCTCTCTCCCTCTG  
0.5DNR2 4332 CTAGCTAGCACAGAGGGAGAGAGGCAGAG pMCDd       126     
  5075 ACCCTGTTCTCTGCTAAGCAG 
5S RNA gene -79 ATATGCTAGCAATTCGAGCTCGCCCCGG pXP10e        282  
  +212 CGAGGTCGACTCTAGAGGA 
5S NPEr -79 ATATCCCGGGAATTCGAGCTCGCCCCGG pXP10e        139         
  +74 ATGCGCTAGCTAACAGGCCCGACCCTGC 
5S NPEf -79 ATATGCTAGCAATTCGAGCTCGCCCCGG pXP10e        153 
  +74 TATACCCGGGTAACAGGCCCGACCCTGC 
SB2r  MCS CTAGATCCCGGGCGACTCTAGAGGATCCCC pUC.SB2+f  161   
  599 CTAGCGGCTAGCACTCCGGGCGACACTTTG     
a refers to the 5’ end of each primer 
b restriction sites for cloning into the vacant DNR site are underlined. “0.5DNR1” 
used the DNR-flanking NheI site (nt # 4219) for the upstream primer. “0.5DNR2” 
used the DNR-flanking XmaI site (previously XbaI in pMCD, nt # 4454) for the 
downstream primer.    
c SV40 intron amplicon, Genbank Accession # U02434 
d Genbank accession # Y09885, positions relative to the BamHI site. 
e nt numbers are relative to the 5S RNA gene transcriptional start site. 
f nt numbers refer to Genbank accession #M12074 or the pUC18 multiple cloning 
site (MCS). 
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Figure 17. Initiation activity of ori-beta constructs at multiple ectopic 
chromosomal sites in pooled stably transfected DR12 cells. (A) Integration of 
full-length ori-beta into DR12 cells was assayed by Southern blot analysis of 
BamHI/KpnI-digested genomic DNA hybridized to ori-beta probes 1 and 2, or 
probe GNAI3 as a loading control. “DR12” refers to untransfected cells, “ori-beta 
CHOK1” refers to the endogenous ori-beta, “ori-beta DR12” refers to stably 
transfected ori-beta sequences in DR12 cells, and “ori-beta plasmid” refers to 30 
pg of pMCD. Densitometry quantitation of ectopic ori-beta was first calculated in 
each lane as [(intensity of 5.8 kb band) / (intensity of 3.5 kb band)], then 
expressed as a percentage (shown below the blot) of the same densitometry 
quantitation done in the CHOK1 lane corresponding to the same µg quantity of 
DNA. (B) Summary of the methodology used to prepare and analyze nascent 
DNA samples. (C) Diagram of ori-beta constructs, with primer sets pp2 and pp3 
shown (gray diamonds). (C, rows I, ii, and vii) Cartoon representation of the 
DHFR ori-beta, with deleted regions shown as dashed lines. (C, rows iii-vi) DNR 
replacement and partial deletion constructs, in the context of the entire ori-beta 
fragment, as described in the Materials and Methods. The DNR region and 
replacement elements are drawn to scale +/- 5 bp.  All construct diagrams in (C) 
correspond to the adjacent name and bar graph in (D). In panel D, “initiation 
activity” is calculated as the abundance of target sequences detected with primer 
set pp2 in nascent-enriched DNA fractions, divided by those detected with primer 
set pp3. For comparison, all initiation activities are expressed as a percentage of 
the initiation activity of pMCD (unmodified 5.8 kb ectopic ori-beta, row i). Each 
bar is the average initiation activity measured from at least 3 independent 
transfections and nascent DNA preparations. Brackets indicate SEM. *, 
significantly lower than the pMCD construct; +, significantly greater than the 
∆DNR construct (student’s t-test, p value<0.05). 
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Results 
 
Characterization of the DNR element.  Deletion of DNR from the 5.8 kb DHFR 
ori-beta at random ectopic chromosomal sites in DR12 hamster cells resulted in a 9-fold 
decrease in initiation activity (7).  To assess whether all or part of the DNR sequence was 
specifically required for full ori-beta activity or whether the DNR element simply 
maintained critical spacing between neighboring elements, we created further deletion 
and substitution mutants of DNR.  Each construct was stably integrated at random 
locations in DR12 cells, and total genomic DNA from pooled transfected cells was 
isolated.  Integration of the intact 5.8 kb BamHI/KpnI ori-beta fragment into the DR12 
hamster genome was monitored by Southern blot using a fragment at the GNAI3 locus as 
a loading control.  In two independent transfections, full-length ori-beta was detected at 
about 1/3 the level of the endogenous ori-beta in CHO-K1 cells (Figure 17A).  Nascent 
DNA of ~0.4-2 kb was obtained by size fractionation of denatured genomic DNA from 
asynchronously growing, pooled transfected DR12 cells.  The abundance of target 
sequence in the nascent DNA fractions was determined by real-time PCR using primer 
sets at the ori-beta initiation site (pp2) and at an outlying site ~3 kb away (pp3) 
(Appendix Table 3, Figure 17C).   
 Using 5.8 kb wild type (WT) ori-beta (pMCD) as a positive control and the DNR 
deletion mutant as a negative control, we measured the initiation activity of ori-beta 
mutant constructs (Figure 17D).  Replacement of the 235 bp DNR element with a 235 bp 
fragment from an SV40 intron (DNRspcr) was not able to rescue initiation activity.  
Reversing the original orientation of DNR (DNRrev) reduced the initiation activity at ori-
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beta, but it remained easily detectable (Figure 17D).  These results indicate that some 
sequence-specific feature of DNR is critical for its role in ori-beta initiation activity at 
random ectopic locations in DR12 cells.          
 The 235 bp NheI-XbaI DNR sequence is composed of 
GCTA(CG)5(CA)19(GA)20(G)10(CAGA)4GGGAGAGAGGCAGAGAGGG(GA)28 
followed by 44 bp of sequence without any repeats.  In vitro studies of the DNR sequence 
showed that the (CG)5(CA)19 sequence can adopt a left-handed Z-DNA conformation, 
and the two (GA)n sequences can adopt triplex DNA structures (18).  To further define 
functional regions within the DNR element, we deleted either the first half (0.5DNR2) or 
the second half (0.5DNR1) of the DNR sequence and tested the initiation activity of each 
of these ori-beta constructs in DR12 (Figure 17D, rows v-vi).  The 0.5DNR1 deletion, 
which removed the (GA)28 and downstream sequences, had only a minor reduction of 
initiation activity as compared to the WT ori-beta construct.  In contrast, the 0.5DNR2 
deletion, which removed the upstream half of DNR up to the CAGA repeats, reduced 
initiation activity to 25% of WT ori-beta.  These results indicate that most of the 
functionality of DNR resides within the first half of its sequence, but that there is a 
smaller contribution from the second half. 
To test if additional functional elements exist downstream of DNR, the entire ~1.3 
kb XbaI-KpnI (XK) downstream region was deleted.  This XK mutant showed initiation 
activity levels equivalent to the DNR deletion, indicating little or no initiation at ori-beta 
(Figure 17D, row vii).  This result suggests that at least one additional ori-beta functional 
element is located downstream of DNR. 
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Two dissimilar transcriptional elements can independently replace the 
function of the DNR element.  The importance of DNR in the initiation activity of 
ectopic ori-beta might also be explained by the activity of DNR as a replication fork 
barrier (RFB), since early studies of the DNR region revealed that it impedes the 
progression of replication forks emanating from an SV40 origin in an orientation-
dependent manner (22).  To test this possibility, the DNR element was replaced with a 
known RFB from the murine 28S rDNA locus (57, 114), such that it would impede 
replication forks moving toward ori-beta (Figure 18B, row ii).  This 161 bp element 
contains a binding site for the Transcription Termination Factor 1 (TTF-1), which binds 
to the second Sal box (SB2) motif at the rDNA locus (65).  In addition to its role in 
termination of transcription and replication elongation, TTF-1 also acts to remodel 
chromatin and activate transcription (98, 99). When the initiation activity of the SB2 
replacement mutant was evaluated at ectopic sites in DR12 cells, ori-beta initiation 
activity was above that of WT ectopic ori-beta (Figure 18C, row ii), indicating that the 
SB2 element is able to functionally replace DNR.   
The non-conserved distal Abf1-binding element in yeast ARS1 is known to limit 
the ability of nucleosomes to mask the ORC-binding site, thereby inhibiting ARS1 
activity (112).  Given the distal location of DNR in ori-beta, we wondered whether DNR 
might also position nucleosomes to facilitate protein binding to elements necessary for 
ori-beta activity, such as AT. To address this possibility, the DNR sequence was replaced 
with the 282 bp Xenopus 5S RNA gene, which contains a well-characterized nucleosome-
positioning element (NPE) (188).  The orientation of the 5S RNA gene replacement sets 
the direction of transcription away from ori-beta.  The 5S RNA gene (5Sf) replacement of 
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DNR displayed initiation activity above that of WT ori-beta (Figure 18C, row iii), 
indicating that the 5S gene was able to functionally replace DNR.   
We next sought to gain more insight into the mechanism of 5S RNA gene 
function as a DNR replacement. The 5S gene could stimulate ori-beta by positioning 
nucleosomes, by recruiting transcription factors via its Transcription Factor IIIA (TFIIIA) 
binding site, or by providing a specific DNA structural conformation (216).  To 
distinguish among these possibilities, new ori-beta constructs were designed in which 
DNR was replaced by a 5S RNA gene lacking the TFIIIA binding site and downstream 
sequences, but with the NPE left intact.  This partial 5S RNA gene was inserted in both 
orientations in place of DNR, and the initiation activity of the resulting ori-beta mutant 
constructs at random ectopic sites in DR12 cells was determined.  Both constructs lacking 
the TFIIIA binding site had sharply reduced initiation activity relative to the complete 5S 
RNA gene replacement, with minor initiation activity detected in the forward, but not 
reverse, orientation (Figure 18C, rows iv-v).  These results suggest that the functional 
replacement of DNR by the 5S RNA gene is dependent on its TFIIIA binding site, and 
not solely on its ability to position nucleosomes.        
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Figure 18. Loss of initiation activity in DNR-deleted ori-beta can be restored by 
transcriptional elements.  (A) Summary of the methodology used to prepare and analyze 
nascent DNA samples.  (B) Diagram of ori-beta constructs, with primer sets pp2 and pp3 
shown (gray diamonds).  The DNR region and replacement elements are drawn to scale 
+/- 5 bp.  (B, row i) Wild type ectopic ori-beta in DR12 cells.  (B, row ii) Arrows above 
and below the SB2 element indicate the polar impediment of replication forks moving 
toward ori-beta (X) mediated by TTF-1 at its binding site (thick line).  (B, row iii) A gray 
arrow indicates the transcription direction of 5S RNA gene, with the nucleosome 
positioning element (NPE, thick line) and TFIIIA binding site (black box) highlighted.  
(B, row iv-v) Partial 5S RNA gene replacements containing the NPE (black bar) without 
the TFIIIA binding site, in either orientation.  Dashed lines indicate deleted regions.  All 
construct diagrams in (B) correspond to the adjacent name and bar graph in (C). In panel 
C, “initiation activity” and notations are as described in the legend of Figure 17. 
 
            
The DNR element is required for ori-beta activity at a specific integration 
site in human cells.  Our characterization of DNR used stably integrated ori-beta 
constructs at random chromosomal locations, but we cannot rule out the possibility that 
the requirement for various sequence elements in ori-beta activity depends on the random 
integration strategy that we used or on the hamster cell environment. In an attempt to 
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confirm the results of Figures 17 and 18 with ori-beta integrated at a specific 
chromosomal site in a different mammalian species, we generated a panel of ectopic ori-
beta constructs at the same specific chromosomal site in the Hela acceptor cell line 406. 
Ectopic wild type and mutant ori-beta cell lines with the DNR deletion, DNR orientation 
reversal (DNRrev), and DNR substitution with an identically-sized DNA fragment spacer 
from an SV40 intron (DNRspcr) (Figure 19) were integrated at the same chromosomal 
site in the Hela acceptor cell line 406, so the resulting lines were completely isogenic 
except for the mutation introduced in each construct.  After G418 and ganciclovir 
screening, the resistant clones were verified by diagnostic PCR analysis (Figure 19A).  
The acceptor cell line 406 showed the specific band using diagnostic primers 1 and 2.  
Conversely, when the FRT site was occupied with a large ori-beta DNA fragment 
mediated by FLP recombinase, primers 1 and 2 did not amplify the corresponding band. 
But primers 1 and 3, located within the Neomycin resistance gene, amplified the expected 
band in all positive ori-beta clones.  Southern blot analysis of EcoRI-digested genomic 
DNA from of these clones used two probes, Hyg and Neo, to verify the integration 
location and integrant copy number (Figure 19B).  Hybridization of the Hyg probe to a 
5.6 kb EcoRI fragment confirmed that integration occurred at the intended chromosomal 
location (Figure 19B, left).  Hybridization of the Neo probe solely to the 5.6 kb band in 
the ori-beta lines indicated that specific integration in the acceptor FRT site had taken 
place (Figure 19B, right). 
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onstruct; DNRrev, construct in which the 
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fully integrated at the specific site in 
h cell line was measured by real-time 
, ppHyg, and ppGlobin (Figure 16, 
d at the human beta-globin locus at 
chromosome 11, was used as an internal reference to compare different cell lines and 
nascent DNA preparations.  In the WT ori-beta line, the abundance of target sequences in 
nascent DNA detected with pp2b was ~15-fold higher than that detected with ppGlobin 
and ~10-fold higher than that with the outlying ppHyg (Figue 4D), indicating that ori-
beta is active at the specific ectopic site in Hela 406 cells.  Deletion of the DNR element 
or substitution with a spacer abolished ori-beta initiation activity, confirming that the 
specific sequence of DNR is critical to its role in regulating DNA replication initiation 
(Figure 19D).  Reversing the original orientation of DNR did not diminish replication 
initiation at ori-beta (Figure 19D).    
Other ori-beta elements contribute to initiation activity in human cells.  Full 
initiation activity of the ectopic ori-beta replicator in DR12 hamster cells was shown to 
require specific DNA sequences in an AT rich element (AT), in the downstream RIP60 
binding site (RIP), and in the bent DNA element (BENT) (8). To assess the importance of 
these elements for the initiation activity of ori-beta at random ectopic chromosomal sites 
in human cells, Hela cells were stably transfected with each of the mutant constructs 
(Figure 20).  Fractions enriched in 0.4-2 kb nascent DNA were prepared from uncloned 
pools of these transfected cells and the abundance of four ori-beta target sequences in 
each fraction was determined by competitive PCR.  Initiation activity was calculated by 
normalizing the abundance of each target to that of an outlying target 3 kb away from the 
initiation site (pp3). In Hela cells, initiation activity of wild-type ectopic ori-beta at pp2 
was about 40-fold greater than that pp3 (Figure 20C).  In contrast, the initiation activity 
of ectopic ori-beta lacking the AT element was greatly reduced.  Moreover, the mutations 
of downstream RIP60 binding site (RIPx) and the bent DNA structure (BENDx) 
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decreased the initiation activity at pp2 to a level similar to that at pp3.  These results are 
consistent with those obtained using a similar strategy in DR12 hamster cells (8). 
We then examined the activity of three ori-beta mutants integrated at a specific 
ectopic chromosomal site in Hela 406 cells.  Integration of these ori-beta constructs at the 
specific integration site was confirmed by PCR and Southern blot analysis (Figure 21A, 
6B).  Compared to the WT ori-beta control, the AT element deletion, RIPx mutation, and 
BENDx mutation each virtually eliminated ori-beta initiation activity at the pp2b site, 
with no enrichment seen above that of the ppHyg and ppGlobin sites (Figure 21D).  The 
results confirm that these three elements are essential for ori-beta activity in human and 
hamster cells, at either random or specific ectopic chromosomal sites.   
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 Figure 20.  Initiation activity of 
ori-beta constructs at multiple 
ectopic chromosomal sites in 
pooled stably transfected Hela 
cells. (A) Diagram of WT ori-beta 
and mutated residues. The 
sequences necessary for the bent 
DNA region (underlined) and 
downstream RIP60 binding site 
(bold) are shown. Nucleotide 
substitutions for the BENDx and 
RIP60 mutants are in parentheses 
and brackets, respectively. (B) 
Summary of the methodology used 
to prepare and analyze nascent 
DNA samples as previously 
described for hamster cells (8). (C) 
“Initiation activity” was calculated 
by dividing the quantity of target 
sequences in nascent-enriched 
DNA fractions detected at primer 
sets pp8, pp2, or pp6 by that 
detected at primer set pp3.  Primer 
set locations are given in Figure 
16B. Construction of these ori-
beta plasmids is described in (7, 
8). Bars are the average 
quantitation of target sequences in 
at least 2 independent transfections 
and nascent DNA isolations. 
Brackets indicate SEM. 
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 Figure 21.  Initiation activity of ori-
beta constructs at the specific
chromosomal site in Hela cells. (A)
PCR-based analysis of clonal cell
lines containing ori-beta constructs,
as described in the Materials and
Methods section and Figure 19A. (B)
Southern blot analysis of EcoRI-
digested genomic DNA from clonal
cell lines, as described in the
Materials and Methods section and
Figure 19B. (C) Summary of the
methodology used to prepare and
analyze nascent DNA samples as
previously described (113). (D)
Analysis of the initiation activity of
ori-beta constructs at the specific
integration site in Hela.  406, Hela
acceptor cell line; WT, full-length
ori-beta fragment.  Mutant constructs
are described in the Materials and
Methods and Figure 20.  “Initiation
activity” is defined as the abundance
of target sequences in nascent-
enriched DNA fractions detected at
primer set pp2b (black bars) or
ppHyg (white bars), divided by that
at primer set ppGlobin. Brackets
indicate SEM for WT. 
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Discussion 
 
Ori-beta constructs can be evaluated using different ectopic integration 
strategies.  In this report, we have measured the Chinese hamster DHFR replicator ori-
beta DNA initiation activity in Hela and DR12 cells at specific and at random ectopic 
chromosomal sites.  Consistent with previous results (7, 8), our investigation showed that 
the 5.8 kb DHFR initiation region ori-beta is active at ectopic sites not only in hamster 
cells, but also in human cells (Figures 17 and 20).  Mutations that disrupted ori-beta 
activity in DR12 or Hela using the non-specific integration system also disrupted 
initiation in the specific site in Hela (compare Figures 17 and 19, 20 and 21).  These 
results provide evidence that the potential pitfalls of non-specific integration, including 
position effects, do not obscure or falsify the determination of ectopic origin function.     
Transcription through the endogenous ori-beta has been shown to inactivate the 
origin (126, 160).   However, transcription of the neomycin resistance gene upstream of 
the site-specific integrated origin constructs in the Hela 406 line should not be a concern, 
since a strong SV40 transcription terminator is located between the neomycin resistance 
gene and the integrated origin fragment (16, 118).  Therefore, transcription elongation 
across the ectopic ori-beta would not be expected to suppress its activity, and this is 
supported by the ori-beta initiation activity seen in the integrated WT ori-beta construct 
(Figure 19).   
The 3’ end of the 5.8 kb ori-beta fragment contains at least two sequence 
elements necessary for ori-beta initiation activity.  Deletion of either the 235 bp DNR 
element or the 1.3 kb XK region downstream of DNR led to a loss of ori-beta initiation 
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activity at non-specific chromosomal sites in DR12 cells (Figure 17D), and the effect of 
the DNR deletion was recapitulated at a specific locus in Hela cells (Figure 19D).  The 
loss of initiation activity upon deletion of the 5’ half of DNR, but not the 3’ half (Figure 
21D), suggests that the main functional component(s) of DNR resides within the first 132 
bp of its 235 bp length.  It also suggests that the loss of initiation activity upon deletion of 
the XK region is not due to the disruption of a necessary element that overlaps the DNR 
and XK, but rather because at least one separate and novel functional element exists 
within the 1.3 kb XK element.  The failure to functionally replace the 235 bp DNR 
element with a 235 bp DNA fragment from an SV40 intron (Figure 17D and 19D) 
indicates that DNR does not serve just to maintain a critical spacing between flanking 
elements, but that its DNA sequence is important.       
Transcription factor binding sites can functionally substitute for DNR.  The 
specific sequence of DNR, in particular the first 132 bp of its 235 bp length, serves some 
functional role in the initiation of DNA replication at ori-beta from over 3 kb away from 
the initiation site.  What functional role might it serve? This 132 bp sequence is as 
follows: GCTAG(CG)4(CA)19(GA)20(G)9(CAGA)4GGGAGAGAGGCAGAGA. The first 
6 bp are a palindromic NheI site, and the rest of the sequence, except for the final 16 bp, 
is repetitive.  These final 16 bp, however, were not sufficient for full initiation activity of 
an ori-beta mutant lacking the repetitive sequences (Figure 17D, 0.5DNR2 mutant).  GA 
repeats have been shown to impede replication forks (22, 80, 153) and affect the 
assembly of DNA into nucleosomes (46), so both of these potential roles were 
investigated separately (Figure 18).  Importantly, a replication fork barrier (SB2) and an 
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element that contains a nucleosome-positioning element (5S rDNA) were each able to 
independently replace the function of DNR (Figure 18C).   
The results implied that these two elements share some functional characteristic 
with the DNR element.  The protein TTF-1, which binds to the SB2 element, is capable 
of actively re-positioning nucleosomes (98), leading us to suspect that SB2 and the 5S 
rDNA substituted for a function of DNR in positioning nucleosomes.  However, since the 
NPE from the 5S gene could not, without the TFIIIA binding site, functionally replace 
DNR (Figure 18C), we conclude that SB2 and 5S rDNA must have additional or 
alternative functions needed to substitute for DNR in ori-beta activity.   
 The general role of transcription factors is to regulate the formation of various 
functional complexes at specific chromosomal sites assembled from elements recognized 
by these factors (93). The functions of transcription factor binding sites may thus 
resemble those of replicator elements needed to assemble ORC and pre-replication 
complexes. Comparison of the two transcription elements that substitute for DNR in the 
ectopic ori-beta replicator may reveal the function of DNR.  The SB2 element contains 
binding sites for TTF-1 and Ku 70/80 heterodimer. These proteins participate in initiation 
of rDNA transcription (69, 99), termination of transcription and replication (151, 200), 
and TTF-1 can also remodel chromatin (98, 99). The 5S gene contains a binding site for 
TFIIIA, which recruits TFIIIC and TFIIIB to form a stable transcription activation 
complex on the 5S gene (100, 216). Thus both transcription elements able to substitute 
for DNR share the ability to gain access to a specific site in chromatin and nucleate 
assembly of a multiprotein complex at that site.  This type of transcription element-
dependent chromatin remodeling, in the absence of transcription, facilitates assembly and 
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function of the V(D)J recombination complex at specific times in lymphocyte 
development (140, 170).  We speculate that both the 5S gene and the SB2 element may 
substitute for DNR by creating a suitable chromosomal environment that is important for 
the essential functions of the flanking AT or XK elements in ori-beta replicator activity.  
The function, but not necessarily the DNA sequence, of cis-acting elements in 
a mammalian replicator promotes initiation of DNA replication.  One of the obstacles 
to understanding mammalian origins has been the lack of identifiable sequence homology 
between different origins.  As shown here, the repetitive sequences in DNR are critical 
for initiation activity of ectopic ori-beta (Figure 17 and 19, (7)), but CA and GA repeats 
are not commonly associated with replication origins.  Moreover, we have shown that the 
DNR element can be functionally substituted by two different unrelated sequences, and 
not by a third sequence (Figure 17, 18). These data provide additional support for the 
hypothesis that cis-acting elements that together comprise a mammalian chromosomal 
replicator can have different DNA sequences in different replicators, yet fulfill the same 
function in origin activity. These data also extend our previous finding that the AT-rich 
element of ori-beta can be functionally replaced by a non-homologous sequence from the 
LaminB2 origin (8) by showing that mammalian transcriptional control elements can also 
substitute for a mammalian replicator element. Detailed characterization of additional 
mammalian replicators, mutant replicators, and the proteins that interact with them will 
be needed in the future to uncover the common functions of replicator elements that 
differ in sequence.       
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CHAPTER IV 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
The Implications of an Origin of DNA Replication at the Human FMR1 Promoter 
 
 Although several other origins have been reported near TNR disease loci, the 
work presented in this thesis is to date the most comprehensive and definitive 
characterization of an origin associated with a trinucleotide repeat tract (28, 136).  Our 
results also demonstrate that the CGG repeats affect PCR efficiency at neighboring 
sequences, and this may be a feature common to TNRs.  If uncut genomic DNA is used 
as a standard for real-time quantitative PCR, NarI/XhoI-digested genomic DNA will 
show an artificial “peak” of abundance near the repeats (data not shown).  This occurs 
because the XhoI/NarI-digested genomic DNA without the repeats amplifies with higher 
efficiency near the repeats when compared to the uncut genomic DNA standard.  Since 
the experimental techniques used to identify the other candidate TNR origins employed 
PCR-based assays to detect initiation events, their results should be verified with this 
consideration in mind.         
Recombination- or repair-mediated repeat instability.  Models of repeat 
instability involving DNA replication are not exclusive of models involving DNA repair 
and/or recombination after fork stalling or collapse (97, 104).  Polymerase stalling within 
the repeats, or DNA secondary structures left after the passage of the replication fork, 
could trigger a DNA damage response and recruit DNA repair machinery.  Secondary 
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structures formed within the repeats might then inhibit proper processing of the broken or 
damaged DNA.  These errors in processing could eventually lead to single-stranded gaps 
or double-stranded breaks (62, 104).  Alternatively, the delay in replication timing seen at 
Fragile X alleles (71, 72, 181, 218) could cause the locus to sometimes remain 
unreplicated by the end of S-phase.  In this case, a DNA damage response would be 
triggered to replicate the region, possibly leading to the same problem of improper 
processing of the CGG repeats. 
The potential role of the FMR1 origin as a safeguard against repeat 
expansion.  Investigations into the role of origins in affecting TNR stability have relied 
on model systems to determine what might occur at TNR loci.  The discovery of an 
origin of DNA replication near the Fragile X CGG repeats reinforces the relevance of 
these investigations in model systems and expands our understanding of TNR stability 
beyond hypothetical models to include an actual disease locus.  The extensive knowledge 
gained from model systems can now be applied to the relationship between the FMR1 
origin and CGG repeats.   
As discussed in chapter 2, the position of the FMR1 origin should favor CGG 
contractions over expansions, according to numerous investigations in model systems 
(reviewed in (104).  Both expansions and contractions occur when unstable CGG repeats 
are integrated next to an origin in S. cerevisiae and COS-1 cells, but contractions are 
favored when CGG is the template of lagging strand synthesis (13, 137).  Random 
expansions and deletions may occur periodically at the FMR1 CGG repeats through 
normal DNA metabolism, but the location of the FMR1 origin relative to the repeats 
should limit the number of expansions.  Thus, the FMR1 origin placement may have 
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evolved as a safeguard mechanism to maintain genomic integrity by limiting expansion 
events at the CGG repeats.  The reason for the failure of this mechanism in Fragile X 
patients will require further investigation.  Also, validation of the hypothesis of origin 
placement as a regulator of repeat stability will require the discovery of additional origins 
near other TNR loci.                  
 
Future Directions for the FMR1 Origin 
 
The comprehensive and conclusive identification of the FMR1 origin provides a 
solid example of an origin normally associated with a disease-relevant TNR.  The FMR1 
origin also provides a way to move beyond model replication systems and study how the 
CGG repeats are normally replicated in their natural setting.  Cells can be grown under 
conditions of replicative stress, such as reduced nucleotide pools (11), to determine 
whether dormant secondary origins might exist at other locations near the CGG repeats.  
This approach may give a clue to how the CGG tract might be replicated during early 
development when replication initiation is hypothesized to be relatively non-specific.  
Cloning the origin and moving it and the CGG tract to an ectopic site could 
provide a wealth of information about how replication from the FMR1 origin affects 
repeat stability.  If the FMR1 origin is positioned to stably replicate the CGG repeats as 
we propose, changing the distance or orientation of the CGG repeats relative to the 
FMR1 origin should disrupt that stability.  By moving the origin to an ectopic site, such 
mutations could be engineered.   
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A systematic deletion of transcription factor binding sites in the FMR1 promoter 
would indicate which of these factors, if any, contribute to the activity of the FMR1 
origin.  Thus, one could use the well-characterized FMR1 promoter to further elucidate a 
potential link between transcription and replication regulation.  Integrating replication 
timing studies into this investigation might uncover the reason for delayed replication of 
the FMR1 locus upon FMR1 silencing. 
The strategy and data presented in chapter 2 should provide a framework for 
future investigations of potential origins at other TNR disease loci.  Although other 
studies suggest that origins may be found near other disease-relevant TNRs, a more 
thorough investigation should uncover whether origins are a common feature associated 
with these loci and the extent of the role that origins may play in stabilizing these and 
other repeat tracts in the genome.   
Finally, the most important questions left unanswered from this investigation are 
whether a change in origin usage at the FMR1 locus actually occurs during development, 
and whether unmethylated, expanded CGG repeats undergo contractions because they are 
replicated from the FMR1 origin.  The 22 week fetal fragile X cell line GM07072 had a 
reduction in FMR1 origin activity, suggesting a developmental change in origin usage.  
Untransformed fetal cells are available from the Coriell cell repository as young as 8 
weeks old.  If the reduction in FMR1 origin usage in early developmental cells is also 
seen in these fetal cells, it would considerably strengthen our hypothesis regarding the 
involvement of FMR1 origin usage in CGG stability in vivo.           
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Discussion of the Ectopic Integration Strategy and the Genetic Dissection of the 
DHFR Origin-Beta 
 
 
Ectopic origin placement: the mammalian version of the yeast ARS assay.  
Understanding the workings of origins of DNA replication is likely to involve a complex 
and dynamic set of interactions, possibly including the regulation of replication factor 
binding, chromatin structure, epigenetic modifications, nuclear localization, association 
with the nuclear matrix, DNA flexibility, and transcription (4, 27, 37, 40, 61, 115, 123).  
Our current understanding of regulatory elements at mammalian origins stems from a 
limited number of often disconnected case examples, which hampers firm conclusions of 
exactly what is needed for DNA replication to initiate at specific chromosomal locations.  
Even though specific DNA sequences were shown to be necessary for replication to 
initiate, the lack of a clear consensus sequence in the origins of higher eukaryotes has 
made a bio-informatics approach to origin identification problematic (4, 60, 61).  The 
report of a possible loose metazoan consensus sequence (149) is provocative but will 
require further investigation.  For now, in order to test the dynamic interactions required 
for replication initiation, ectopic systems for origin mutational analysis are critical, just as 
the use of ectopically-expressed reporter genes have been essential for elucidating the 
components of gene promoters.  The use of stably-integrated origin fragments, either site-
specific or random, new ARS-like episomal analyses of origin function (84, 149, 183), 
and eukaryotic viral origins (202) each have different benefits and caveats.  A rigorous 
comparison of these systems should facilitate the efficient progression of our 
understanding of origins of DNA replication.   
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The results and conclusions presented in Chapter 3 demonstrate that the DNA 
sequence components required for origin activity can be genetically investigated using 
stable ectopic integration of origin constructs at either non-specific or specific integration 
sites.  If these methods are largely equivalent, as the data in Chapter 3 suggest, the non-
specific integration system represents the quickest and technically easiest method for 
testing the effects of genetic mutations within the origin fragment.  However, the non-
specific integration system has the disadvantage that the origin copy number and 
chromatin context in each cell is variable, making some biochemical analyses of ectopic 
origin fragments potentially problematic.  Within a pool of randomly integrated origin 
fragments, some origins may be active and some may be inactive, but initiation activity is 
measured as the average initiation activity at all locations.  Assaying for DNase or 
MNase hypersensitive sites, for example, would be easier to interpret at a specific 
integration site where all origins are isogenic.  When assaying such sites in a mixed 
population of active and inactive origins in different chromosomal contexts, the results 
may be more difficult to interpret. 
The human laminB2 origin and hamster DHFR ori-beta are capable of functioning 
at multiple ectopic chromosomal locations (7, 8, 141), suggesting that elements necessary 
for creating the required chromosomal context are contained within the ectopic origin 
fragment.  This may not be the case with other cloned fragments of mammalian origins, 
and more case examples will be required before the viability of the non-specific ectopic 
system is accepted as a general test applicable to origins.  However, since we directly 
compared the specific and non-specific systems for analyzing ori-beta constructs for 
initiation activity and found them to be equivalent, we have bridged a gap between the 
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investigations of ori-beta and the investigations of the c-myc and beta-globin origins at 
specific chromosomal locations.   
 Replacement of origin cis-elements with functional elements containing non-
homologous sequences.  Mammalian origins of DNA replication are comprised of 
multiple cis-acting functional sequence elements (4).  As discussed in Chapter 3, some 
investigations of mammalian origin functional elements have successfully swapped non-
homologous sequences that can function independently to promote origin activity (8, 58).  
The successful substitution of the DNR element with Xenopus and murine ribosomal 
RNA transcriptional elements illustrates the concept that transcription factors do more 
than just promote transcription (93).  Another illustration of this concept is seen during 
V(D)J recombination, where transcription factor binding, but not transcription, is 
required for recombination (140, 167).  Although these transcription elements were able 
to substitute for DNR, at this point it is unclear what role they, or DNR, are playing in 
promoting replication initiation at ori-beta.        
 
Future Directions for the DHFR Origin-Beta  
 
What is DNR doing?  Although DNR can be functionally replaced with the 5S 
RNA gene or the SB2 element (Figure 18), it is still unclear what these three elements 
have in common.  Of course, it is also formally possible that these elements have nothing 
in common and are promoting ori-beta activity by completely different mechanisms.  A 
clarification of these results could be obtained by replacing DNR with only the TFIIIA or 
TTF-1 binding sites, to determine if the functional replacement of DNR is due to these 
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transcription factors alone.  The DNR replacement data suggests that the first 132 bp of 
the DNR element may be binding some type of trans-acting protein factor that has a 
similar function to TFIIIA, TTF-1, and/or Ku70/80.  To understand what DNR is doing, it 
would be very helpful to know what, if any, proteins are binding to DNR.   
Possible DNR binding proteins.  GA repeats in approximately 250 Drosophila 
genes serve as the binding site for the trithorax-like GAGA-factor (GAF) protein, a 
transcription activator/repressor and chromatin-remodeling factor (101, 102, 192, 209).  
GAF has been described as “establishing the transcriptional potential of genes without 
necessarily leading to gene expression” (206).  It also plays an important role in proper 
chromosome segregation during mitosis (17).  The functions of GAF appear to overlap 
with TTF-1, and its role in DNR to create a favorable chromatin environment is plausible.  
Although a clear homolog for Drosophila GAF has not been described, the hamster and 
mouse protein Pur1 binds GA repeats and is a potent transcriptional activator of the rat 
insulin promoter in hamster, mouse, rat, and human Hela cells (91).  The human 
transcription factor MAZ is the homolog of Pur1 with 94% sequence identity (178).  
Interestingly, MAZ (Myc-associated Z-finger protein) binds to the c-myc gene P1 and P2 
promoter regions within and flanking the well-characterized c-myc origin (20, 41).  Pur1 
or MAZ would be a good candidates for potential DNR-binding proteins, and future 
investigations should begin with these two proteins.               
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APPENDIX 
 
APPENDIX TABLE 3.  Real-time PCR primers 
Primer name Sequence (5’ to 3’)   [Mg++]   Ta* Location**    Size*** 
MCM4 (Genbank accession # U63630)        
EX6b-F TACCTGTGGGTAAGAGATGAGTTG 3.5 mM  60° 10691  209 bp 
EX6b-R CTCTATACATGCAACGACTTGGG    10900 
UPR4-F GGACATTACAGATGCATTTCTC  3 mM   60° 13119  215 bp 
UPR4-R AAGAGTTCCAAGTTTGTTCCTC    13334   
UPR5-F CCCCCGACCGCGTTTGTCGTTT  3 mM   64° 13284  198 bp 
UPR-R1 GGCCAGTAAGCGCGCCTCTTTGG    13482 
LaminB2 (relative to replication start site (2))       
LB2C1-SX GTTAACAGTCAGGCGCATGGGCC  3.5 mM  60° -3931  240 bp 
LB2C1-DX CCATCAGGGTCACCTCTGGTTCC    -3691 
#BE-SX ACTTTCTGAAGGAGGCTCTG  4 mM   60° -1623   192 bp 
#BE-DX GGCAATAGCTCACCGTTTAC    -1431    
LO-F  GCGTCACAGCACAACCTGC  3.5 mM  60° -136   266 bp 
LO-R  TCTTTCTTAGACATCCGCTTC    +130    
B48-SX TAGCTACACTAGCCAGTGACCTTTTCC 3.5 mM  60° +173  167 bp  
B48IIb-DX GACTGGAAACTTTTTTCTACAAC    +6    
SE17-SX AATTTCCACTCCACAGCCGT  2 mM   64° +2532  208 bp 
SE17-DX TAGGAGTGACCCTAGTGACT    +2324    
 
Fragile X (Genbank accession # L29074)        
FraX-30 SX CCTGAAAGGATAAATCTTGCCC  3.5 mM  60° 35023  191 bp  
FraX-30 DX CCTATGTTCAGATCTTCAACCC    35214 
FraX-20 SX AACCCTATTTCTGGCTCTGGAC  3.5 mM  60° 24999  185 bp 
FraX-20 DX CCCTCCAAGTTATCAAAGATTCC    25184   
FraX-16 SX AGTCAATTATTGGGGTCAACCAC  3 mM   60° 17238  205 bp 
FraX-16 DX GGGCAGAAATCAGAAACTCCAG    17443 
#FraX-14 SX GGTCTGCACTGATGGAAGAAC  3.5 mM  64° 16070  182 bp 
#FraX-14 DX TAACACTTCTCCACAGCAGTTC    16252    
FraX-12 SX TTTCAGGAAGACCCTAACATGG  3.5 mM  60° 14658  199 bp  
FraX-12 DX GAAGTTTCATGGCATATATTTAGG   14857    
#FraX-11.5 SX TGAGCTGGGGATGGGCGAGG  2 mM     64° 14276  182 bp 
#FraX-11.5 DX AGGAGGCGGCCCGGCTGAAG    14458    
FraX-11 SX TCCAATGGCGCTTTCTACAAGG  3 mM   62° 13922  244 bp  
FraX-11 DX GCTGGTCTCTCATTTCGATAGG    14236  
FraX-1c SX TCTGTCTTTCGACCCGGCAC  3 mM   64° 13527  211 bp 
FraX-1c DX GGAAGTGAAACCGAAACGGAG    13738    
FraX-1d SX GCGCGTCTGTCTTTCGACCC  3.5 mM  64° 13529  224 bp 
FraX-1d DX  CCCTCCACCGGAAGTGAAACC    13753 
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APPENDIX TABLE 3. (cont.) 
 
FraX-1.2 SX TCTGCAGAAATGGGCGTTCTGG  3 mM   64° 13425  178 bp 
FraX-1.2 DX CTCTCTCTTCAAGAGGCCTGGG    13603    
FraX-1.4 SX CCTATTCTCGCCTTCCACTCC  2 mM   62° 13247  188 bp 
FraX-1.4 DX     ATTTCTGCAGAGGTGCACTCA    13435 
FraX-1.5 SX TCCCGACTCAATCCATGTCCC  2 mM   62° 13051  188 bp  
FraX-1.5 DX AGGCGAGAATAGGGGTGAAGG    13239    
FraX-2 SX AGCATCCCGAAGGGAACATGG  2 mM   58° 12747  189 bp  
FraX-2 DX ACTGTATGTGCACCCTGTGCC    12936  
#FraX-2.5 SX GAATGTGGCCCTAGATCCACC  3.5 mM  60° 12331  205 bp  
#FraX-2.5 DX AGAATAGGCGCTTCCATGATGG    12536    
FraX-3 SX CTGAAAACCTTAAGGTGCAGGG  3.5 mM  60° 11963  185 bp  
FraX-3 DX CTCCAAGTGTAAGCTGTTGTTC    12148  
#FraX-3.5 SX CTAGATGCCCGATCAGTAGGG  3.5 mM  60° 11561  223 bp 
#FraX-3.5 DX TGCAATATGTTCGATAGAGATCC    11784    
FraX-5 SX AACAGTGCTGGAATAACTGGAC  3.5 mM  60° 9998  197 bp  
FraX-5 DX CTTCACTTCATTCCAGTGCATG    10195    
#FraX-6 SX TCTGCTGACACTGTAATGGTGG  3.5 mM  60° 9598  184 bp 
#FraX-6 DX GTACTTCCTAATCTCAATCTCCCTCCTC   9782    
#FraX-6.5 SX AGGAAGTCTCACTCATTGCTGG  3.5 mM  60° 9056  189 bp 
#FraX-6.5 DX GGCTCCTGTAAACTTTCTTGTAC    9245    
#FraX-7 SX GTAACAGATCTGAGCAGACACC  3.5 mM  62° 8870  199 bp 
#FraX-7 DX GAGTGAGACTTCCTGTTACTCC    9069    
FraX-10 SX ATACATGCAAAGGGCTAGGTCC  3.5 mM  60° 1024  180 bp 
FraX-10 DX GATCTCTCTATGCTTCAGTTTCC    1204 
 
Hamster DHFR ori-beta (Relative to BamHI site at position 1)      
#pp12-SX GAGCAGCAAGGAACTGAAG  3.5 mM  58° 16  246 bp 
#pp12-DX GTGTATTACTGCACAGTAGCA    262 
pp8-SX CTCTCTCATAGTTCTCAGGC  3.5 mM  58° 470  200 bp 
pp8-DX GTCCTCGGTATTAGTTCTCC    670    
#pp2a-SX GTCCCTGCCTCAAAACACAA  3 mM    58° 1070  122 bp 
#pp2a-DX TAGTGCGTCTTTAAGACCTG    1192 
pp2-SX GTCCCTGCCTCAAAACACAA  3.5 mM  58° 1070  278 bp 
pp2-DX CTGCCTTCATGCTGACATTTGTC    1348    
pp2b-SX GCACTAGATGCTGAACTTAACAG  3.5 mM  58° 1184  164 bp 
pp2b-DX CTGCCTTCATGCTGACATTTGTC    1348 
pp6-SX AACTGGCTTCCCAAGAAATT  3.5 mM  58° 1517  168 bp 
pp6-DX AACCTCTGAACTGTAAGCTG    1685    
pp3-SX GGACACTAAGTCTAGGTACTACA  3.5 mM  58° 3882  258 bp 
pp3-DX GCTGGGATAAGTTGAAATCC    4140 
#ppK12-SX CAGGACCAATGTGATACAAC  3 mM     58° 5389  185 bp 
#ppK12-DX AGCTTAAGGCTCACTTATGG    5574 
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APPENDIX TABLE 3. (cont.) 
 
Human beta-Globin locus (Genbank #GI455025)       
#Globin40.9-SX GCAAGCAATACAAATAAT  3 mM    58° ~40900 156 bp  
#Globin40.9-DX ACCACAAACACAAACAGG    ~40900 
Globin54.8-SX      3.5 mM  60° ~54800 
Globin54.8-DX        ~54800   
#Globin62-SX GAGGTACGGCTGTCATCACTT  3 mM   58° 62005  210 bp 
#Globin62-DX CAGGGCAGTAACGGCAGA    62214 
#Globin62.2-SX CCTGAGGAGAGGTCTGGCGT  2 mM   60° 62220  207 bp 
#Globin62.2-DX CCTAAGGGTGGGAAAATAGACC    62427    
#Globin62.4-SX GGTCTATTTTCCCACCCTTAGG  3 mM   60° 62406  209 bp 
#Globin62.4-DX CAGTGCAGCTCACTCAGTGT    62615 
#Globin72-SX CCAGAATCTACAATGAACTC  3.5 mM  60° 72319  135 bp 
#Globin72-DX TGATGGCTAGTGATGATG    72453 
 
FRT integration site (113)           
ppHyg-F TGCTCCGCATTGGTCTTGA  2 mM   60°   73 bp 
ppHyg-R TGCGCCCAAGCTGCAT 
ppNeo1-SX GAAGGGACTGGCTGCTATTGG  2 mM     60°   201 bp 
ppNeo1-DX TGATCGACAAGACCGGCTTCC        
ppTK-F AGCAAGAAGCCACGGAAGTC  2 mM    60°   102 bp 
ppTK-R GTTGCGTGGTGGTGGTTTTC 
ppTK3-SX GCGACGATATCGTCTACGTACCC  3.5 mM  64°   182 bp 
ppTK3-DX CGGTCACGGCATAAGGCATG 
 
RT-PCR of cDNA           
FMR1 E13-F ACAAAGGACAGCATCGCTAATG  3.5 mM  60° 42386  193 bp 
FMR1 E14-R CCATTCCTTGACCATCATCAGTC    45046 
#FMR1 E1-4F CTCCAATGGCGCTTTCTACAAG  ?       ? 13982  198 bp 
#FMR1 E1-4R AGGCTCTTTTTCATTTGCTCTGG    30133    
#HDHB E5-6F TGTGAGCACTCCAAACTTTCTAAGC ?       ? exon 5a 156 bp 
#HDHB E5-6R GCTGAGATTCTGCTCTATGGTTTGTC   exon 6a
#HDHB E10-F GAAAGTAACGTTCGACTGTGCAATG 4 mM   60° exon 10a 191 bp 
#HDHB E11-R CTGAAAAGTGTGAATAGTTCTTGC   exon 11a  
#ACTB E1-3F AGCACAGAGCCTCGCCTTTG  3.5 mM  60° 14b  202 bp 
#ACTB E1-3R TGACCCATGCCCACCATCAC    216b
 
*“Ta” refers to the annealing temperature of the primer set. 
** The location for each primer set refers to the 5’ end of the primer.  
***Size refers to the amplicon length of each primer set. 
# indicates primers not described elsewhere in this document 
a human HDHB gene
b human beta-actin cDNA sequence; nt corresponds to Genbank accession # BC002409 
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APPENDIX TABLE 3. (cont.) 
 
Notes on primers:
• Each reaction is done as a “touchdown” reaction consisting of 50 total cycles.  
The first 5 cycles uses an annealing temperature of Ta+4°, the next 5 cycles uses 
an annealing temperature of Ta+2°, and the final 40 cycles are done at the 
annealing temperature listed for each primer.  The exception is those reactions 
with a Ta of 64: these use Ta+2° for 5 cycles, Ta+1° for 5 cycles, and the Ta for 40 
cycles. 
• The cycling parameters were as follows:  10 minutes at 95°; 5 cycles at 95° for 15 
sec, Ta+4° for 5 sec, and 72° for 15 sec; 5 cycles at 95° for 15 sec, Ta+2° for 5 
sec, and 72° for 15 sec; 40 cycles at 95° for 15 sec, Ta for 5 sec, and 72° for 15 
sec.  Some CG-rich amplicons used a melting temperature of 96° or 97° (these are 
listed below). 
• The incubation times are very short because of the Roche LightCycler used.  All 
reactions are done in glass capillary tubes in an open-air chamber, which allows 
very fast heating and cooling.  If the reactions are done in another format all 
conditions will need to be adapted accordingly. 
 
CG-rich amplicons: 
Primer set Melting temperature
1c  96° 
1d  96° 
1.2  96° for the first 10 min incubation, then 97° for all others 
11  96° 
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APPENDIX TABLE 4.  Real-time PCR efficiencies of target sequences in various DNA 
samples from HCT116 cells  
 
  genomic HCT116 (cut) a  gen. HCT116 (uncut)  nascent HCT116 
Primer set slopeb errorc eff.d  slopeb errorc eff.d slopeb errorc eff.d 
EX6b  -3.266 0.0526 2.02  -3.163 0.0249 2.07 -3.305 0.0699 2.01 
UPR4  -3.438 0.0581 1.95  -3.765 0.0870 1.84     -3.453 0.0795 1.95 
 
LB2C1  -3.626 0.1090 1.89  -3.360 0.0633 1.98     -4.019 0.1730 1.77   
B48IIb    -3.621 0.0586 1.89  -3.374 0.0643 1.98     -3.690 0.0718 1.87  
 
10  -3.239 0.0379 2.04  -3.235 0.0627 2.04 -3.754 0.127 1.85  
3  -3.315 0.0489 2.00  -3.347 0.0518 1.99 -3.436 0.0416 1.95  
1.5  -3.574 0.0854 1.90  -3.618 0.1060 1.89 -3.118 0.0738 2.09  
1.4  -3.470 0.1040 1.94  -3.680 0.1940 1.87 -3.509 0.1080 1.93 
1.2  -3.114 0.0715 2.08  n.d.e   -4.039 0.1500 1.77   
1c  -3.289 0.0924 2.01  -5.621 0.0354 1.51  -3.913 0.0685 1.80  
1d  -3.118 0.0468 2.09  n.d. e   -4.362 0.1230 1.70  
11  -3.822 0.0427 1.83  -4.216 0.039 1.73  -4.377 0.0559 1.69  
20  -3.269 0.0372 2.02  n.d. e   -3.425 0.1030 1.96  
 
a The MCM4 and FMR1 primer sets were used to amplify genomic DNA cut with NarI 
and XhoI.  The LaminB2 primer sets used genomic DNA cut with NarI only, since XhoI 
cuts within the B48IIb amplicon. 
b Slope of the line when the crossing point of serial dilutions of the given sample are 
plotted against the LOG of the sample starting concentration 
c Error (mean squared error) is calculated by the Roche LightCycler software using the 
equation [Error = Σ(∆x*2)/n], where ∆x = the vertical distance between data point and 
regression line and n = number of data points.   
d eff. (Efficiency) is calculated from the slope with the equation (efficiency = e –1/slope).  
An efficiency of 1 refers to no amplification, and an efficiency of 2 refers to perfect 
amplification. 
e no data.  Samples were not tested. 
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APPENDIX TABLE 5. Nascent DNA quantitations.      
*raw values correspond to the copy number equivalent in 1 pg of genomic HCT116 DNA 
[cut with XhoI/NarI]  (so a "3108" nascent DNA raw value has the same copy number as 
3108 pg genomic HCT116)  
*raw values are the average of 2 duplicate real-time PCR reactions   
*Note: there is approximately one diploid genome per 6pg in HCT116   
            
500-1000 bp HCT116 nascent DNA         
 prep#1 prep#2 prep#3 prep#4   
primerraw norm. raw norm. raw norm. raw norm.  Aver. SD 
EX6b 3108 1.0 2646 1.0 2604 1.0 2016 1.0  1.00 0.00 
UPR4 34092 11.0 26430 10.0 26772 10.3 20160 10.0  10.31 0.46 
UPR5 29898 9.6 25662 9.7 31392 12.1 20166 10.0  10.34 1.15 
            
LB2C1 6546 1.0 4920 1.0 6876 1.0 4704 1.0  1.00 0.00 
LO 49854 7.6 48018 9.8 46758 6.8 32202 6.8  7.76 1.39 
B48IIb57840 8.8 50760 10.3 46542 6.8 33552 7.1  8.26 1.64 
            
10 2112 0.8 1896 0.9 1260 0.9 1062 1.0  0.88 0.06 
3 2586 1.0 2226 1.0 1626 1.1 1134 1.0  1.05 0.06 
2 7068 2.7 4548 2.1 4284 3.0 3738 3.4  2.80 0.52 
1.5 10332 4.0 7452 3.5 8868 6.2 7536 6.8  5.11 1.63 
1.4 17166 6.6 12810 6.0 18150 12.7 11820 10.7  8.97 3.22 
1.2 3018 1.2 2580 1.2 3756 2.6 2328 2.1  1.77 0.71 
1c 3372 1.3 2238 1.0 3048 2.1 2850 2.6  1.76 0.71 
1d 1410 0.5 684 0.3 1398 1.0 1398 1.3  0.77 0.42 
11 1044 0.4 1032 0.5 1200 0.8 1122 1.0  0.68 0.29 
12 4632 1.8 3108 1.5 3510 2.4 2286 2.1  1.94 0.42 
20 3138 1.2 2280 1.1 1416 1.0 1128 1.0  1.07 0.09  
*all values are for 2uL 1:4 dilution of original nascent preps  
            
1000-2000 bp HCT116 nascent DNA        
 prep#1 prep#2 prep#3 prep#4  Aver. SD 
primerraw norm. raw norm. raw norm. raw norm.    
EX6b 1650 1.0 1950 1.0 1782 1.0 1596 1.0  1.00 0.00 
UPR4 8922 5.4 16218 8.3 12390 7.0 13008 8.2  7.21 1.34 
UPR 5 12714 7.7 21288 10.9 16914 9.5 17658 11.1  9.79 1.56 
            
LB2C1 2004 1.0 2136 1.0 1560 1.0 1926 1.0  1.00 0.00 
LO n.d.  n.d.  n.d.  n.d.     
B48IIb10572 5.3 10332 4.8 6972 4.5 10380 5.4  4.99 0.42 
            
10 870 0.6 1488 0.7 948 0.7 732 0.7  0.69 0.03 
3 1668 1.2 2568 1.2 1374 1.0 1260 1.2  1.17 0.10 
2 3966 2.9 6684 3.2 4650 3.5 2922 2.8  3.09 0.30 
1.5 4500 3.3 7428 3.5 5448 4.1 5118 4.9  3.95 0.71 
1.4 8772 6.4 15318 7.3 9066 6.7 8934 8.6  7.26 0.93 
1.2 1026 0.8 2052 1.0 2208 1.6 2160 2.1  1.36 0.60 
1c 1362 1.0 3588 1.7 3636 2.7 2964 2.8  2.06 0.87 
1d 1356 1.0 1206 0.6 804 0.6 1176 1.1  0.82 0.28 
11 432 0.3 936 0.4 1164 0.9 1218 1.2  0.70 0.39 
12 1656 1.2 1638 0.8 1878 1.4 3168 3.0  1.61 0.99 
20 1548 1.1 2232 1.1 1710 1.3 1140 1.1  1.14 0.09  
*all values are for 2uL 1:4 dilution of original nascent preps 
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APPENDIX TABLE 5. (cont.)        
   
500-1000 bp Hela S3 nascent DNA         
 prep #1 prep #2  Aver. SD   
primerraw norm. raw norm.     
EX6b 372 1.0 754 1.0  1.00 0.00  
UPR4 1454 3.9 2342 3.1  3.51 0.57  
         
LB2C1 681 1.0 2038 1.0  1.00 0.00  
B48IIb2067 3.0 7618 3.7  3.39 0.50  
         
10 280 0.5 281 0.6  0.56 0.03 
3 842 1.6 693 1.4  1.53 0.12 
1.5 2380 4.6 3695 7.7  6.14 2.22 
1.4 2248 4.3 3662 7.6  5.98 2.35 
1c 1293 2.5 3778 7.9  5.19 3.82 
11 209 0.4 362 0.8  0.58 0.25 
20 439 0.8 463 1.0  0.91 0.09      
*all values are for 3uL original nascent preps (out of a total of 100uL) 
 
500-1000 bp PFW nascent DNA         
 prep #1  prep #2  Aver. SD  
primerraw norm. raw norm.     
EX6b 135 1.0 82 1.0  1.00 0.00  
UPR4 990 7.3 692 8.4  7.89 0.78  
         
LB2C1 302 1.0 183 1.0  1.00 0.00  
B48IIb1176 3.9 1524 8.3  6.11 3.14  
         
10 156 0.9 86 0.5  0.74 0.29  
3 207 1.3 226 1.4  1.33 0.10  
1.5 1374 8.3 1231 7.6  8.00 0.49  
1.4 2107 12.8 721 4.5  8.64 5.88  
1c 470 2.9 754 4.7  3.77 1.29  
11 105 0.6 198 1.2  0.93 0.42  
20 131 0.8 171 1.1  0.93 0.19      
*all values are for 2uL original nascent preps (out of a total of 100uL)  
 
500-1000 bp GM05381 nascent DNA        
 prep #1 prep #2 prep #3 prep #4  Aver. SD 
primerraw norm. raw norm. raw norm. raw norm.    
EX6b 15.6 1.0 6.4 1.0 36.7 1.0 22.6 1.0  1.00 0.00 
UPR4 98 6.3 43 6.7 250 6.8 207 9.2  7.24 1.30 
            
LB2C1 94 1.0 36 1.0 201 1.0 76.0 1.0  1.00 0.00 
B48IIb394 4.2 234 6.5 764 3.8 782 10.3  6.20 2.98 
            
10 25 0.3 11 0.5 23 0.6 75 0.8  0.55 0.22 
3 181 2.1 34 1.6 93 2.3 138 1.5  1.87 0.36 
1.5 237 2.8 133 6.2 225 5.5 203 2.3  4.18 1.97 
1.4 397 4.6 194 9.1 251 6.1 603 6.7  6.63 1.86 
1c 245 2.8 126 5.9 0 0.0 34 0.4  2.28 2.73 
11 65 0.8 0 0.0 0 0.0 94 1.0  0.45 0.53 
20 52 0.6 19 0.9 7.5 0.2 57 0.6  0.58 0.29  
*all values are for 2uL original nascent preps (out of a total of 100uL) 
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APPENDIX TABLE 5. (cont.) 
 
500-1000 bp GM08400 nascent DNA        
 prep #1 prep #2  Aver. SD 
primerraw norm. raw norm.    
EX6b 9.5 1.0 18.8 1.0  1.00 0.00 
UPR4 82 8.6 208 11.1  9.85 1.72 
        
LB2C1 120 1.0 232 1.0  1.00 0.00 
B48IIb416 3.5 396 1.7  2.59 1.24 
        
10 37 0.5 57 0.3  0.38 0.13 
3 88 1.1 373 1.9  1.49 0.51 
1.5 154 2.0 796 4.0  2.97 1.40 
1.4 128 1.6 1459 7.3  4.45 3.97 
1c 452 5.8 1371 6.8  6.31 0.73 
11 73 0.9 76 0.4  0.66 0.39 
20 109 1.4 173 0.9  1.13 0.38      
*all values are for 3uL original nascent preps (out of a total of 100uL) 
 
500-1000 bp GM05848 nascent DNA        
 prep #1  prep #2 Aver. SD 
primerraw norm. raw norm.    
EX6b 10 1.0 25 1.0  1.00 0.00 
UPR4 30 3.0 126 5.0  4.02 1.44 
        
LB2C1 51 1.0 62 1.0  1.00 0.00 
B48IIb114 2.2 244 3.9  3.09 1.20 
        
10 37 1.3 21 0.8  1.04 0.38 
3 42 1.5 36 1.3  1.41 0.11 
1.5 105 3.7 197 7.3  5.51 2.53 
1.4 324 11.5 283 10.5  10.98 0.70 
1c 21 0.7 69 2.6  1.65 1.28 
11 26 0.9 17 0.6  0.78 0.21 
20 5.7 0.2 24 0.9  0.55 0.49      
*all values are for 2uL original nascent preps (out of a total of 100uL) 
 
500-1000 bp GM04026 nascent DNA        
 prep #1  prep #2 Aver. SD 
primerraw norm. raw norm.    
EX6b 135 1.0 62 1.0  1.00 0.00 
UPR4 275 2.0 248 4.0  3.02 1.39 
        
LB2C1 97 1.0 127 1.0  1.00 0.00 
B48IIb195 2.0 302 2.4  2.19 0.26 
        
10 73 1.0 57 0.5  0.73 0.38 
3 105 1.4 218 1.8  1.61 0.24 
1.5 516 7.1 206 1.7  4.37 3.81 
1.4 921 12.6 548 4.5  8.54 5.77 
1c 164 2.2 159 1.3  1.77 0.67 
11 107 1.5 73 0.6  1.03 0.62 
20 41 0.6 94 0.8  0.66 0.14     
*all values are for 2uL original nascent preps (out of a total of 100uL) 
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APPENDIX TABLE 5. (cont.) 
 
500-1000 bp GM07072 nascent DNA        
 prep #1 prep #2 prep #3  Aver. SD 
primerraw norm. raw norm. raw norm.    
EX6b 2562 1.0 228 1.0 124 1.0  1.00 0.00 
UPR4 25940 10.1 1732 7.6 2100 16.9  11.55 4.83 
          
LB2C1 5772 1.0 474 1.0 225 1.0  1.00 0.00 
B48IIb25282 4.4 2448 5.2 1958 8.7  6.08 2.30 
          
10 2165 0.6 200 0.5 113 0.7  0.59 0.13 
3 4471 1.1 419 1.0 186 1.2  1.12 0.11 
1.5 14932 3.8 1876 4.4 541 3.5  3.93 0.47 
1.4 10558 2.7 1083 2.6 370 2.4  2.56 0.16 
1c 8922 2.3 2061 4.9 78 0.5  2.56 2.20 
11 1858 0.5 238 0.6 48 0.3  0.45 0.13 
20 5030 1.3 650 1.5 164 1.1  1.30 0.24    
*all values are for 3uL original nascent preps (out of a total of 100uL) 
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APPENDIX TABLE 6.  Quantitative RT-PCR of FMR1 mRNA 
      
Cell Line  primer set     
   FMR-13/14 Average STD dev % of HCT   
HCT #1  6094  5837.33 831.27  100.000 
HCT #2  6510     
HCT #3  4908     
HAF #1  6507  6349.67 282.09  108.777 
HAF #2  6024     
HAF #3  6518     
GM05381 #1  5250  5292.00 244.72  90.658 
GM05381 #2  5071     
GM05381 #3  5555     
GM08400 #1  5463  5517.67 800.40  94.524 
GM08400 #2  6344     
GM08400 #3  4746     
GM07072 #1  42  30.67  12.66  0.525 
GM07072 #2  33     
GM07072 #3  17     
GM04026 #1  0.56  0.28  0.28  0.005 
GM04026 #2  0     
GM04026 #3  0.29     
GM05848 #1  1.4  1.30  0.17  0.022 
GM05848 #2  1.4     
GM05848 #3  1.1          
*template = 0.5uL of 20uL cDNA reaction (cDNA reaction used 1ug total RNA as 
template)      
*Standard = serial dilutions of HCT116 #1 PCR product (1 corresponds to ~1 trillionth of 
the reaction product)      
*Each value is the average of two real-time PCR reactions done in parallel  
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APPENDIX TABLE 7.  Relative RNA quantitation by densitometry of Figure 9B 
        
Lane Sample volume minus background normalized    
1 HCT  425624 184013  0.98 
2 HAF  439968 198357  1.06 
3 GM05381 452190 210579  1.12 
4 GM08400 411653 170042  0.91 
5 GM07072 424373 182762  0.97 
6 GM04026 435037 193426  1.03 
7 GM05848 415351 173740  0.93 
8 EMPTY 241611 0        
 AVERAGE 1-7:  187560  
 
*1 ug of total RNA was loaded in each lane     
*Densitometry was done using IPlabgel software     
*"background"" was determined by measuring volume in an empty lane   
*Normalization was achieved by dividing the volume of each lane by the average across 
all lanes 
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APPENDIX FIGURE 22 
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APPENDIX FIGURE 22 (cont.) 
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APPENDIX FIGURE 22 (cont.) 
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APPENDIX FIGURE 22 (cont.) 
 
Appendix Figure 22.  Characterization of real-time PCR primers.  PCR conditions were 
optimized for each primer set at the MCM4 locus (A-C), Lamin B2 locus (D-F), Fragile 
X locus (G-T), and FMR1 cDNA (U) to give a single detectable product after 50 cycles.  
Left panels: Real-time PCR products produced in magnesium titration experiments were 
electrophoresed on an agarose gel and stained with ethidium bromide (M = marker, 
numbers to the side of the gel indicate sizes in bp).  In each case, the H2O lane shows 
products generated when water was used instead of template with 3 or 3.5 mM Mg++.   
The middle panel of each row shows a sample melting curve analysis of PCR 
products amplified using genomic HCT116 DNA template in duplicate, or with water as 
a negative control.  In these experiments, the PCR products after 50 cycles are re-
annealed, then the temperature is gradually raised while fluorescence is measured.  The 
derivative of the fluorescence is given to show a peak at the temperature where the 
product melts.  In instances where a small amount of non-target product is observed with 
a lower melting temperature (as in row Q), the reaction is raised above that temperature 
before fluorescence is measured whenever possible, so only the target product is detected.  
Arrows indicate the temperature at which fluorescence is measured for each primer set.  
In rows D and P, small products are seen on the agarose gel when water is used instead of 
template, but the melting curve analysis shows that these products melt below 72°C. 
The right panel of each row shows a sample standard curve for each primer set 
using serial dilutions of HCT116 genomic DNA.  The tight fit of the points to the line on 
each curve indicates a broad concentration range and minimal error for the quantitation of 
starting DNA template.   
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NUCLEOSOMES HAVE AN ORDERED ARRANGEMENT AROUND THE DNR 
ELEMENT AT ORI-BETA IN CHINESE HAMSTER OVARY (CHO) CELLS. 
 
  
Introduction 
 
A microarray-based investigation of nucleosome positioning in S. cerevisiae 
revealed that functionally important genomic sequences such as gene promoters have an 
ordered arrangement of nucleosomes, but other regions of DNA have essentially random 
placement of nucleosomes (220).  Presumably, this trend occurs because the correct 
positioning of nucleosomes is necessary for many DNA-binding proteins to access their 
target sites (108, 195, 196, 213).  To investigate the pattern of nucleosome positions 
around the DNR region, we used an in vivo micrococcal nuclease (MNase) sensitivity 
assay.  Purified DNA from MNase-treated chromatin is digested with a specific 
restriction enzyme to create a uniform end to fragments at the region of interest.  
Following Southern blotting, a probe is hybridized to the sequence immediately flanking 
the restriction site, thus indirectly end-labeling all of the MNase fragments from the 
region of interest that share a common end at the restriction site.  Fragment lengths 
indicate the nearest site of MNase cleavage on each molecule of DNA.  Discrete bands 
appearing on the Southern blot indicate groups of DNA lengths corresponding to areas on 
chromatin hypersensitive to MNase.  Since MNase cuts preferentially in the ~50 bp linker 
region between 146 bp nucleosome core particles, this method has been used to 
determine the approximate positions of nucleosomes on chromatin in vivo (207).  
However, tightly associated protein complexes can also create a nucleosome-like gap in 
MNase accessibility (194). 
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Materials and Methods 
 
MNase-hypersensitive sites were detected in vivo on chromatin essentially as 
previously described (26).  Briefly, purified nuclei containing intact chromatin from 
CHO-K1 cells was subjected to limited digestion with MNase (Sigma), then digested 
overnight at 37°C with Proteinase K and purified with repeated phenol:chloroform 
extractions, RNase A digestion, and ethanol precipitation.  The purified MNase-treasted 
DNA was then digested with either DraIII or HinDIII, to create uniform ends in the 
population of MNase fragments around DNR.  Forty µg of MNase-treated DNA, with or 
without restriction enzyme digestion, was electrophoresed through a 1.4% agarose gel 
and blotted to a Highbond N+ membrane (Amersham #RPN203B) for Southern blot 
analysis.  Southern blot hybridization and washes were performed as described above for 
the non-specific integration system using Church buffer.  The probe D for DraIII-digested 
DNA was a 210 bp fragment located immediately upstream of a DraIII site at nucleotide 
5028 (relative to the BamHI site upstream of ori-beta).  Probe D was amplified by PCR 
using the primer sequences 5’-TCTTTTAAGATACTTGGCCCC-3’ and 5’-
GTGCCACATCCCTGATGATC-3’.  Probe H for HinDIII-digested DNA was a 208 bp 
fragment located immediately upstream of a HinDIII site at nucleotide 4636 (relative to 
the BamHI site).  Probe H was amplified by PCR using the primer sequences 5’-
ATCAGACTGGTCCCATATCC-3’ and 5’-TTAGAAATTCATCATGAAAAATCTG-
3’.  By using probes located immediately next to restriction enzyme cut sites, MNase 
fragments at the region of interest are indirectly end-labeled at the restriction site when 
visualized after Southern blot hybridization. 
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Results and Discussion 
 
 The region next to a DraIII site downstream of DNR was investigated using the 
MNase-sensitivity assay.  Probe D hybridized only to a 1118 bp band in non-MNase-
treated, DraIII-digested genomic CHO-K1 DNA, indicating the expected DraIII fragment 
(Figure 23A and 23B, lane 1).  Probe D did not show any appreciable hybridization to 
MNase-treated DR12 hamster DNA, which lacks the ori-beta sequence, indicating that 
probe D bound specifically to the ori-beta target sequence (Figure 23B, lane 2).  A ladder 
of mono-, di-, tri-, and poly-nucleosome-sized DNA fragments in MNase-treated CHO-
K1 DNA suggests that nucleosomes around the probe D sequence have a specific 
arrangement (Figure 23B, lanes 3 and 5).  Hypersensitive sites observed in MNase-
treated, DraIII-digested CHO-K1 DNA suggests an ordered arrangement of nucleosomes 
specifically between the DraIII site and DNR (Figure 23B, lanes 4 and 6).  These results 
suggest an ordered arrangement of nucleosomes immediately downstream of the DNR 
element at the endogenous ori-beta in CHO-K1 cells. 
 To analyze the pattern of nucleosome positions across the DNR sequence, the 
MNase-hypersensitivity assay was repeated using a HinDIII site downstream of DNR.  
Probe H hybridized to only a 1625 bp sequence corresponding the expected size of the 
HinDIII fragment in HinDIII-digested genomic CHO-K1 DNA (Figure 23A and 23C, 
lane 4), but it did not hybridize appreciably to any sequences in DR12 MNase-treated 
DNA (Figure 23C, lane 3), indicating that probe H hybridized specifically to its target 
sequence in ori-beta.  A ladder of hypersensitive sites corresponding to the sizes 
nucleosome particles was observed in MNase-treated CHO-K1 DNA, suggesting that the 
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nucleosomes have a specific pattern around the HinDIII site (Figure 23C, lane 1).  These 
hypersensitive sites were visible after the MNase-treated DNA was digested with 
HinDIII, suggesting that nucleosomes have an ordered arrangement across DNR (Figure 
23C, lane 2).  An ordered arrangement of nucleosomes around DNR suggests that a 
specific arrangement may be needed for the binding of trans-acting factors and/or that the 
peculiar sequence of DNR is able to position nucleosomes. 
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Appendix Figure 23. A regular pattern of MNase hypersensitive sites is detected at and 
around the DNR element. (A) Diagram of the DHFR ori-beta with pertinent HinDIII- and 
DraIII-digestion fragments labeled. The location of the HinDIII fragment-specific (H) 
and DraIII fragment-specific (D) probes are drawn as gray lines. (B, C) Southern blots of 
MNase-digested chromatin from CHOK-1 and DR12 cells, with or without restriction 
enzyme digestion. Probe D (panel B) or probe H (panel C) were hybridized to the blots. 
The locations where sequences of the DNR element (shaded box) and probe hybridization 
sites (gray line) would migrate on the gel are drawn next to the blots. MNase sites (bold 
arrows) and nucleosome-sized spaces (gray ovals) are drawn for clarity. Below each blot, 
+ shows the use of MNase or restriction digestion, as indicated. The sizes corresponding 
to the 1118 bp DraIII fragment (B) or 1625 HinDIII fragment (C) are shown. 
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